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Abstract 
The assessment of direct and indirect effects with time-varying and multiple 
mediators is a common but challenging problem, and standard mediation analysis 
approaches are generally not applicable in this context. This dissertation focused on 
extending mediation analysis into a setting with time-varying and multiple mediators. An 
interventional approach has been used to define and identify the direct and indirect 
effects as well as path specific effects based in a causal inference framework, propose a 
parametric approach to estimate these effects, and provide an algorithm as well as 
corresponding software for practical application.  
  In the first paper, we develop a parametric estimation approach to the mediational 
g-formula, including a feasible algorithm implemented in a freely available SAS macro. 
In the Framingham Heart Study data, we apply this method to estimate the interventional 
analogues of natural direct and indirect effects of smoking behaviors sustained over a 
10-year period on blood pressure when considering weight change as a time-varying 
mediator. Compared with non-smoking, smoking 20 cigarettes per day for 10 years was 
estimated to increase blood pressure by 1.18 (95 % CI: -0.68, 2.69) mm-Hg. The direct 
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effect was estimated to increase blood pressure by 1.52 (95 % CI: -0.25, 2.90) mm-Hg, 
and the indirect effect was -0.34 (95 % CI: -0.52, -0.13) mm-Hg, which is negative 
because smoking leads to lower weight which leads to lower blood pressure. These 
results provide evidence that weight change in fact partially conceals the detrimental 
effects of cigarette smoking on blood pressure. Our work represents the first application 
of the parametric mediational g-formula in an epidemiologic cohort study. 
  The second paper proposes an approach to conduct mediation analysis for survival 
data with time-varying exposures, mediators, and confounders. We identify the direct and 
indirect effects through a survival mediational g-formula and provide the required 
assumptions. We also provide a feasible parametric approach along with an algorithm 
and software to estimate these effects. We apply this method to analyze the Framingham 
Heart Study data to investigate the causal mechanism of smoking on mortality. The risk 
ratio of smoking 30 cigarettes per day for ten years compared with no smoking on 
mortality is 2.34 (95 % CI = (1.44, 3.70)). Of the effect, 7.91 % is mediated by coronary 
artery disease. The survival mediational g-formula constitutes a powerful tool for 
conducting mediation analysis with longitudinal data. 
Finally, the third paper further proposes a method, defining a randomly 
interventional analogue of path-specific effect, which can always be non-parametrically 
identified under assumptions of no unmeasured confounding. This method also allows 
settings with mediators dependent on each other, interaction, and mediator-outcome 
confounders which are affected by exposure. In addition, under linearity and 
no-interaction, our method has the same form of traditional path analysis for path-specific 
effect. Furthermore, under a single mediator without a mediator-outcome confounder 
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affected by exposure, it also has the same form of the results of causal mediation analysis. 
We also provide SAS code for settings of linear regression with exposure-mediator 
interaction and perform analysis in Framingham Heart Study dataset, investigating the 
mechanism of smoking on systolic blood pressure mediated by both cholesterol and body 
weight. Allowing decomposition of total effect into several analogues of path-specific 
effects, our method contributes to the investigation of complicated causal mechanisms in 
settings with multiple mediators. 
Key words: causal inference; effect decomposition; mediation analysis; path-specific 
effect; survival outcome; time-varying; multiple mediators; g-formula; parametric 
approach; stochastic intervention.  
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Abstract 
The assessment of direct and indirect effects with time-varying mediators and 
confounders is a common but challenging problem, and standard mediation analysis 
approaches are generally not applicable in this context. The mediational g-formula was 
recently proposed to address this problem, paired with a semi-parametric estimation 
approach to evaluate longitudinal mediation effects empirically. In this paper, we develop 
a parametric estimation approach to the mediational g-formula, including a feasible 
algorithm implemented in a freely available SAS macro. In the Framingham Heart Study 
data, we apply this method to estimate the interventional analogues of natural direct and 
indirect effects of smoking behaviors sustained over a 10-year period on blood pressure 
when considering weight change as a time-varying mediator. Compared with 
non-smoking, smoking 20 cigarettes per day for 10 years was estimated to increase blood 
pressure by 1.18 (95 % CI: -0.68, 2.69) mm-Hg. The direct effect was estimated to 
increase blood pressure by 1.52 (95 % CI: -0.25, 2.90) mm-Hg, and the indirect effect 
was -0.34 (95 % CI: -0.52, -0.13) mm-Hg, which is negative because smoking leads to 
lower weight which leads to lower blood pressure. These results provide evidence that 
weight change in fact partially conceals the detrimental effects of cigarette smoking on 
blood pressure. Our work represents the first application of the parametric mediational 
g-formula in an epidemiologic cohort study. 
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Introduction 
Mediation analysis, a method to decompose the total effect of an exposure on an 
outcome into direct and indirect effects through a mediator, is essential for investigating 
pathways or mechanisms in epidemiology and in the social sciences. Causal mediation 
analysis, defining natural direct and indirect effects based on counterfactual models, 
extends traditional mediation analysis to settings involving nonlinearities and interactions 
1,2
. Numerous methodological approaches based on causal mediation analysis have been 
developed in recent years allowing different outcome scales, including additive, 
multiplicative, and odds ratio scales, as well as other models for time to event data 3-8. 
Most of the approaches mentioned above only consider a point exposure and a 
subsequent point mediator. When conducting causal mediation analysis with longitudinal 
data, the restriction of only one single exposure and mediator neglects exposures or 
mediators at other time-points, which thus potentially results in loss of valuable 
information.  
 Robins has proposed the g-formula to estimate the total effect in settings with 
time-varying exposures and confounders 
9
. In addition, when mediators can be intervened 
upon, the g-formula can estimate the controlled direct effect (CDE) by comparing the 
effects of two different exposure levels and specifying the mediators at certain fixed 
values. For mediation, however, the natural direct effect (NDE) and the natural indirect 
effect (NIE) involved in effect decomposition are, unfortunately, not identified. 
VanderWeele and Tchetgen Tchetgen 
10
 proposed the mediational g-formula to overcome 
the methodological challenges of causal mediation analysis with time-varying mediators. 
As discussed below, this method decomposes the randomized interventional analogue of 
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total effect (rTE) into interventional analogues of natural direct effect (rNDE) and 
indirect effect (rNIE) and moves beyond the limitations of a single exposure and a single 
mediator. Time-varying confounders can also be accounted for provided no unobserved 
confounding is present. For estimation of the rNDE and rNIE, VanderWeele and 
Tchetgen Tchetgen proposed a semi-parametric approach based on inverse probability 
weighted (IPW) estimators. As with standard IPW, this approach is potentially unstable if 
the exposure is continuous or the weights are highly variable. Instead, we consider an 
alternative approach that is potentially more stable and efficient, by implementing a fully 
parametric mediational g-formula approach, using a user-friendly algorithm implemented 
in freely available software. We then apply this method to the Framingham Heart Study 
(FHS) data to investigate the effect of smoking on blood pressure mediated by weight 
change.  
 
Case study for Framingham dataset: smoking, weight, and blood pressure 
In past research, the association between smoking and blood pressure has been 
controversial 
11-16
. In some studies, average blood pressure, as measured using a domestic 
blood pressure monitor 
17-19
, is lower among smokers than among non-smokers at 
particular times of the day 
14,20
. According to most literature, among former smokers, 
smoking cessation increases blood pressure 
21,22
 while some studies fail to find this 
association significant 
23
. 
Three possible mechanisms might explain this association. First, smoking activates 
the autonomic nervous system (ANS) to increase blood pressure directly, but smoking 
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cessation also activates the ANS, increasing blood pressure among former smokers 
24,25
. 
Second, smoking elevates blood pressure through exacerbating arterial stiffness. Third, 
smoking decreases blood pressure through weight loss 
21
. The adverse effect of smoking 
on elevated blood pressure might thus be partially concealed by weight loss. Because 
both smoking status and weight change vary over time, the mediational g-formula is an 
can be used to study the extent of this adverse effect mediated by weight loss. In this 
study, we obtain the estimates by applying our method to the FHS data and demonstrate 
an application of causal mediation analysis with time-varying mediators.  
 
Methods Development 
Notation and review for causal mediation analysis 
 First consider a setting with an exposure, mediator, and outcome measured at a 
single time. Let A denote an exposure, Y an outcome, and M a mediator. Let V denote a 
set of baseline covariates not affected by the exposure. The relations among these 
variables are described in Figure 1.1. Under counterfactual models 
26,27
, Ya and Ma denote 
the counterfactual values of the outcome and the mediator, respectively, if exposure A is 
set to level a. Yam denotes the counterfactual value of the outcome if exposure A is set to 
level a, and mediator M is set to level m. In addition, YaMa* denotes the counterfactual 
value of the outcome if exposure A is set to level a and mediator M is set to level Ma*. 
Under the consistency assumption 
6,28,29
, Ya = Y and Ma = M if A = a; Yam = Y if A = a 
and M = m; and the composition assumption that YaMa* = Y if A = a and M = Ma*.  
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 Mediation analysis decomposes the overall effect into a direct effect (the effect not 
through the mediator) and an indirect effect (the effect through the mediator). Under the 
above counterfactual models, causal mediation analysis usually defines the TE, NDE, and 
NIE to represent the overall, direct, and indirect effects, respectively. Let A = a and A = 
a
*
 denote two hypothetical intervention statuses, exposure and non-exposure, respectively. 
The TE is defined as E[Ya - Ya*] or equivalently, E[YaMa - Ya*Ma*]; the NDE is defined as 
E[YaMa* - Ya*Ma*], and the NIE is defined as E[YaMa - YaMa*]. These effects have been 
described extensively elsewhere and arguments have been made that they are 
theoretically appealing for effect decomposition 
1,2,6
. However, in the presence of 
time-varying confounders, the NDE and NIE are not generally identified from data even 
if these confounders are observed 
30,31
. To address the problem of identification, an 
alternative definition uses the rTE, rNDE, and rNIE to represent the overall, direct, and 
indirect effects, respectively 
32-34
. Let Ga denote a random draw from the distribution of 
the mediator amongst those with exposure status A = a. When exposure is set to a (or a*), 
the distribution of mediator among whole population is also determined. Therefore, for 
every individual, a random draw from this distribution, Ga (or Ga*), will be independent 
of the counterfactual mediator, Ma (or Ma*) and outcome (Yam). The rTE is defined as 
E[YaGa] - E[Ya*Ga*]. The rNDE is defined as E[YaGa*] - E[Ya*Ga*], which can be 
interpreted as an effect on the outcome comparing exposure versus no exposure with the 
mediator in both cases randomly drawn from the distribution of the population when 
given no exposure. Finally, the rNIE is defined as E[YaGa] - E[YaGa*], interpreted as an 
effect on the outcome of randomly assigning an individual who is given exposure to a 
value of the mediator drawn from the distribution of the mediator amongst those given 
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exposure versus not given exposure. We have the decomposition: E[YaGa]- E[Ya*Ga*] = 
(E[YaGa] - E[YaGa*]) + (E[YaGa*] - E[Ya*Ga*]), so the overall effect decomposes into the 
sum of the effect through the mediator (i.e. the indirect effect) and the direct effect. 
 For the NDE and the NIE, both effects can be identified under four assumptions: (1) 
Yam⊥A|V (no unmeasured exposure-outcome confounder); (2) Yam⊥M|V, A (no 
unmeasured mediator-outcome confounder); (3) Ma ⊥ A|V (no unmeasured 
exposure-mediator confounder); and (4) Yam⊥Ma*|V (no mediator-outcome confounder 
affected by exposure) 
6,30
, when ⊥ denotes independence and X ⊥ Y | Z denotes that 
X is independent of Y conditional on Z. Under these assumptions, NDE and NIE are 
identified by the following expressions: 
 
NDE= 
∑ ∑ {E[Y|a, m, v] − E[Y|a∗, m, v]}P(m|a∗, v)mv P(v) 
(1) 
NIE= 
∑ ∑ E[Y|a, m, v]{P(m|a, v) − P(m|a∗, v)}mv P(v) 
(2) 
 The fourth assumption holds only under a non-parametric structural equation model 
and would be violated under several settings. The most common one is the existence of a 
mediator-outcome confounder L that is affected by exposure (Figure 1.2), in which case 
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the fourth assumption fails, even if this confounder is observed. When this confounder is 
a single binary variable, Tchetgen Tchetgen and VanderWeele proposed a method to 
identify the NDE and NIE by assuming the monotonicity about the effect of exposure on 
this confounder 
35
. A severe shortcoming of this assumption is that even if the mediator is 
restricted to occurring immediately after the exposure, the assumption cannot be ensured. 
As a result, this approach is not generally applicable for settings with time-varying 
mediators. However, even if this assumption fails, given assumptions (1) to (3) hold and 
the mediator-outcome confounder is observed, the rNDE and rNIE in the second 
definition are still identifiable from the data by the empirical expressions given by 
34
: 
 
rNDE= 
∑ {E[Y|a, l, m, v]P(l|a, v) − E[Y|a∗, l, m, v]P(l|a∗, v)}P(m|a∗, v)v,l,m P(v) 
(3) 
rNIE= 
∑ E[Y|a, l, m, v]P(l|a, v) {P(m|a, v) − P(m|a∗, v)}v,l,m P(v) 
(4) 
 To understand the difference in the effects better, note that the NDE and NIE cannot 
be checked by designing a randomized trial even if we were able to intervene on both the 
exposure and the mediator. However, it is possible to design a two-stage trial to estimate 
rNDE and rNIE. A randomized trial could first be conducted to obtain the empirical 
distribution of counterfactual mediator given exposed and non-exposed by randomizing 
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the exposure and measuring the mediator distributions. We can then estimate rNIE in a 
second trial by the effect on the outcome of assigning an individual who is given the 
exposure to a value of the mediator sampled from the marginal distribution of the 
mediator amongst those given exposure versus no exposure, using the empirical 
distributions of the mediator estimated from the first randomized trial. Similarly, we can 
estimate rNDE by a direct effect comparing exposure versus no exposure with the 
mediator in both cases randomly drawn from the empirical distribution of the population 
when given no exposure, which was also estimated from the first randomized trial.  
 
Notation and review of mediation analysis with time-varying mediators and the 
mediational g-formula 
 Consider exposures, mediators, and confounders that vary over time in longitudinal 
settings with T measurements at time t = 0, 1, 2, ..., T-1. Let (A(0), A(1), ..., A(T-1)), 
(M(0), M(1), ..., M(T-1)), and (L(0), ..., L(T-1)) denote values of the time-varying 
exposures, mediators, and confounders at periods 1,..., T, with the final outcome of 
interest Y. The initial baseline confounders are included in L(0). Figure 1.3 depicts a 
possible data generating mechanism under which these assumptions would hold. 
 For any variable W, let W(t)̅̅ ̅̅ ̅̅  = (W(0),W(1), ..., W(t)) and let W̅ = W(T − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  = 
(W(0), W(1), ..., W(T-1)). Let Yam̅̅̅̅̅ be the counterfactual value of Y given A̅ is set to a̅ 
and M̅ is set to m̅. Let Ma̅(t) be the counterfactual value of M(t) given A(t)̅̅ ̅̅ ̅̅  is set to 
a(t)̅̅ ̅̅ ̅. Let Ga̅(t) denote a random draw from the distribution of the mediator Ma̅(t). Let 
A̅ = a̅ and A̅ = a∗̅ denote two hypothetical intervention statuses, for example, exposed 
10 
 
from t = 0 to T-1 and non-exposed from t = 0 to T-1, respectively. In this setting, we 
define TE, NDE, and NIE as E[Ya̅] − E[Ya∗̅̅ ̅] (i.e. E[Ya̅M̅a̅] − E[Ya∗̅̅ ̅M̅a∗̅̅ ̅]), E[Ya̅M̅a∗̅̅ ̅] −
E[Ya∗̅̅ ̅M̅a∗̅̅ ̅], and E[Ya̅M̅a̅] − E[Ya̅M̅a∗̅̅ ̅], repectively; while rTE, rNDE, and rNIE are defined 
as E[Ya̅G̅a̅] − E[Ya∗̅̅ ̅G̅a∗̅̅ ̅], E[Ya̅G̅a∗̅̅ ̅] − E[Ya∗̅̅ ̅G̅a∗̅̅ ̅], and E[Ya̅G̅a̅] − E[Ya̅G̅a∗̅̅ ̅], repectively. We 
also can decompose the TE into the NDE and NIE. Similarly, rTE is decomposed into 
rNDE and rNIE (i.e.,E[Ya̅G̅a̅] − E[Ya∗̅̅ ̅G̅a∗̅̅ ̅] = E[Ya̅G̅a∗̅̅ ̅] − E[Ya∗̅̅ ̅G̅a∗̅̅ ̅] + E[Ya̅G̅a̅] − E[Ya̅G̅a∗̅̅ ̅]. 
If the entire vector A̅ = A(T − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  is taken as the joint exposure of interest and M̅ 
= M(T − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  as the mediators of interest, then assumption (4) is violated because the 
variable L(1) is affected by A(0) and confounds the mediator-outcome relationship 
between M(1) and Y (similarly, the L(t) is affected by A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅ and confounds the 
relationship between M(t) and Y, when t = 1, ...,T-1). Therefore, NDE and NIE cannot be 
identified in this setting. However, rNDE and rNIE are still identifiable under the 
following three assumptions for all t: (1) Yam̅̅̅̅̅⊥A(t) | A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, M(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, L(t)̅̅ ̅̅ ̅  (no 
exposure-outcome confounding conditional on the past variables), (2) Yam̅̅̅̅̅ ⊥
M(t)|A(t)̅̅ ̅̅ ̅̅ , M(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, L(t)̅̅ ̅̅ ̅ (no mediator-outcome confounding conditional on the past 
variables), and (3) Ma̅(t) ⊥ A(t) | A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, M(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, L(t)̅̅ ̅̅ ̅ (no exposure-mediator 
confounding conditional on the past variables)
10
). Given the three assumptions, 
VanderWeele and Tchetgen Tchetgen
10
 show that the rNDE and rNIE are identified 
non-parametrically by the following equations: 
 
rNDE = Q(a̅, a∗̅) − Q(a∗̅, a∗̅) 
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(5) 
rNIE = Q(a̅, a̅) − Q(a̅, a∗̅)  
(6) 
where Q(a̅1, a̅2) 
= 
∑ ∑ E[Y|a1̅, m̅, l]̅ ∏ P(l(t)|a1(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ )
T−1
t=0l̅m̅
× ∑ ∏ P(m(t)|a2(t)̅̅ ̅̅ ̅̅ ̅, m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l′(t)̅̅ ̅̅ ̅)P(l
′(𝑡)|a2(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ )
T−1
t=0l′̅
   
(7) 
As in VanderWeele and Tchetgen Tchetgen, we refer to this expression Q(a̅1, a̅2) 
above as the mediational g-formula. When there are no mediators, i.e. M̅ equals empty, 
this formula (7) reduces to the standard g-formula:  
Q(a̅) = 
∑ E[Y|a1̅, l]̅ ∏ P(l(t)|a1(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , l(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ )
T−1
t=0l̅
   
(8) 
Further, rNDE (5) and rNIE (6) reduce to the NDE and NIE, respectively, when there are 
no time-varying confounders 
10
.  
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Parametric mediational g-formula 
VanderWeele and Tchetgen Tchetgen described how to use IPW of marginal 
structural models (MSM) to estimate the mediational g-formula Q(a̅1, a̅2) (7) in realistic 
high-dimensional settings 
10
. However, this approach can perform poorly with continuous 
exposures and mediators and can also be inefficient. As an alternative, an adaptation of 
the standard parametric g-formula 
9,36
 can be used to parametrically estimate the 
mediational g-formula in high-dimensional settings and, in turn, the rNDE (5) and rNIE 
(6).  
We begin by briefly reviewing the standard parametric g-formula. This approach 
parametrically estimates the standard g-formula by (i) fitting parametric models for the 
joint density of the outcome and time-varying covariates and (ii) using the estimated 
parameters of these models to simulate many covariate histories consistent with the 
exposure intervention a̅. Specifically, the following algorithm, which is implemented in 
a publicly available SAS macro 
37
, can be used to parametrically estimate the standard 
g-formula Q(a̅):  
(1) Fit parametric models for the observed data: 
(1a) For times t ≥ 0, fit parametric models for the joint density of the confounders and 
exposures at t given the measured past. 
(1b) Fit a parametric model for the mean of the outcome at the end of follow-up given 
the measured past. 
 (2) Set baseline confounders and exposures to the observed sample values. Recursively, 
for each subject i = 1, …, n and for each time t = 0, 1, 2, …, T-1:  
13 
 
(2a) For t ≥ 0, generate time t confounders and exposures based on the estimated 
model coefficients of (1a) and previously generated exposures and confounders 
under intervention. 
(2b) Assign time t exposures under intervention a̅. 
(3) Simulate the outcome for each of the n generated histories in step 2 based on the 
estimated model coefficients of (1b). 
(4) Take the mean over n simulated outcomes in (3) to estimate Q(a̅). 
 
Here, we have adapted the above algorithm and associated SAS macro code to 
parametrically estimate the mediational g-formula Q(a̅1, a̅2), the rTE, the rNDE, and the 
rNIE. The primary difference between the parametric g-formula and the parametric 
mediational g-formula is, under the latter algorithm, the estimated model coefficients 
from step (1) are additionally used to estimate the joint distribution of the time-varying 
mediators (marginal over all other covariates) under both exposure interventions a̅ and 
a∗̅. These are then used to assign values of the mediator under the joint exposure and 
mediator interventions (a̅,G̅?̅?), (a̅,G̅𝑎∗̅̅ ̅), (a
∗̅,G̅?̅?) and (a∗̅,G̅𝑎∗̅̅ ̅). The algorithm is as follows:  
(1) Fit parametric models for the observed data: 
(1a) For times t ≥ 0, fit parametric models for the joint density of the confounders, 
exposures and mediators at t given the measured past. 
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(1b) Fit a parametric model for the mean of the outcome at the end of follow-up given 
the measured past. 
(2) Estimate the joint distribution of time-varying mediators under time-varying exposure 
interventions a̅ and a∗̅: 
(2a) Set baseline (t = 0) covariates to the observed values for subject i. Recursively, 
for each time t = 0, …, T-1 and each subject i = 1, …, n: 
(2a.i) For t ≥ 0, generate time t confounders, exposure, and mediator based on 
the estimated model coefficients of (1a) and previously generated 
covariates under the time-varying exposure intervention a̅ through 
t-1. 
(2a.ii) Assign time t exposure under the intervention a̅.   
(2b) For each t = 0,…T-1, randomly permute the n values of the joint mediators 
assigned under intervention a̅ in (2a). For each t, save this permutation for use in 
(3) below (we obtain G̅a̅ in this step). 
(2c) Repeat (2a) replacing intervention a̅ with a∗̅.   
(2d) Repeat (2b) replacing intervention a̅ with a∗̅ (we obtain G̅a∗̅̅ ̅ in this step). 
(3) Estimate Q(a̅, a̅), Q(a̅, a∗̅), Q(a∗̅,a̅) and Q(a∗̅, a∗̅) by repeating the following for each 
(a1̅, a2̅̅ ̅) = (a̅, a̅), (a̅, a∗̅), ( a∗̅, a̅) and (a∗̅, a∗̅): 
(3a) Recursively for each time t = 0,…,T-1 and each subject i = 1,…,n: 
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(3a.i) Repeat (2a.i) but replacing “time-varying exposure intervention a̅ 
through t-1’’ with the joint “time-varying exposure and mediator 
intervention (a1̅, G̅𝑎2̅̅̅̅ )’’. 
(3a.ii) Assign the time t mediator as the i
th
 component of the permuted vector 
for time t from (2b) (if a2̅̅ ̅ = a̅) or (2d) (if a2̅̅ ̅ = a∗̅). 
(3a.iii) Assign time t exposure under the intervention a1̅. 
(3b) Simulate the outcome given each of the i = 1,…,n histories based on the estimated 
model coefficients of (1b) and the histories generated in (3a). 
(3c) Estimate Q’(a1̅, a2̅̅ ̅) as the mean over the n simulated outcomes in (3b).    
(3d) Repeat (1) to (3c) for some fixed number K (e.g. 25) times, using different 
permutation in (2b) for each time. 
(3e) Estimate Q(a1̅, a2̅̅ ̅) as the mean of the K (e.g. 25) values of Q’(a1̅, a2̅̅ ̅) in (3d). 
 
The algorithm can stop at (3c) and use the Q’(a1̅, a2̅̅ ̅) as the unbiased estimate of 
Q(a1̅, a2̅̅ ̅). However, the repeated steps in (3d) can improve standard errors for smaller 
sample sizes. Estimates of the rNDE and rNIE are then calculated from the estimates of 
the four Q(a1̅, a2̅̅ ̅) in (3). 95% confidence intervals are calculated based on repeating the 
above algorithm in 500 bootstrap samples of the original n observations. This algorithm 
can be implemented with the mgformula macro, freely accessible with documentation at 
http://www.hsph.harvard.edu/causal/software/. Please see the Appendix 1 for details. 
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Data Application 
Beginning in 1948 in Framingham, Massachusetts, the FHS is a longitudinal cohort 
study. The original cohort consists of 5,209 participants aged from 30 to 62 years old 
without cardiovascular disease (CVD) history at baseline. All the participants underwent 
examinations at the beginning of the study and routinely every two years after that. 
During each exam, potential CVD risk factors were collected, including 
socio-demographic data, lifestyle characteristics, detailed medical history, physical 
examination data, and blood samples. Further details on the design of FHS have been 
described elsewhere 
23,38
. The purpose of the analysis here is to illustrate the parametric 
meditational g-formula approach and software.  
 We specify exam 3 as the first exam and exams 1 and 2 as pre-baseline covariates to 
allow the function of the past in the models of step (1) of the estimation algorithm to 
depend on two lagged periods of the covariates. We follow the cohort for ten years (i.e. 
five visits) to reduce the proportion of death or loss to follow up to limit selection bias by 
death. Four exclusion criteria are listed below: (1) death or loss to follow up during the 
period before exam 7 (the end of follow-up); (2) no record at baseline on weight, height, 
smoking status, former smoking history, systolic blood pressure (SBP), or total 
cholesterol; (3) diagnosis of diabetes, cancer, or CVD at baseline; and (4) missing value 
for smoking status or BMI missing more than once. After these exclusions, 3,116 
participants remain eligible for our analysis. For simplicity, we now refer to the original 
FHS exams 3,..., 7 as exams 1,..., 5. 
 SBP at exam 5 is the outcome Y. BMI during follow-up (exam 1 to 5) is the 
mediator M̅ . The exposure A̅  is smoking status during follow up, measured as 
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self-reported average number of cigarettes smoked per day. For missing BMI value or 
smoking status at a single time period, we carry forward the last observed value/status for 
one exam period only. We consider "smoking 20 cigarettes per day" and "no smoking" 
during follow-up as two hypothetical intervention levels A̅  = a̅  and A̅  = a∗̅ . 
Time-varying covariates L̅  include the exam number, the systolic blood pressure 
(mm-Hg) at last exam, total non-fasting cholesterol level (mg/dl), and the usage of 
antihypertensive drugs. Baseline covariates include gender, age (years), height (meters), 
education (≤ 8th grade, some high school, high school graduate, some college, college 
graduate, post-graduate), occupation before retirement (executive/supervisory, technical, 
laborer, clerical, sales, housewife), marital status (single, married, widowed/divorced), 
and tobacco use at baseline (never user, current user, and past user). All covariates and 
the corresponding models are listed in Table 1.1. 
 The parametric g-formula is used to estimate the TE of smoking 20 cigarettes per 
day v.s. no smoking on SBP and on BMI at exam 5, by the g-formula macro. The 
parametric mediational g-formula is applied to conduct mediation analysis with 
time-varying mediators and exposures by our newly developed mgformula macro. We 
specify models for the outcome mean, as well as for each time-varying covariate 
(including mediator, exposure, and confounders) at each time point. We use current 
covariates and covariates at one period back (one lagged model) as the predictors. 
Specifically, we regress Y on main effects for A(5), M(5), L(5), A(4), M(4), and L(4). 
For t = 0, 1, 2, ..., 5, we regress L(t) on A(t-1), M(t-1), and L(t-1); regress M(t) on A(t), 
A(t-1), M(t-1), L(t), and L(t-1); and regress A(t) on A(t-1), M(t-1), L(t), and L(t-1) 
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(please refer to the Appendix 1 for more details). All analyses are conducted using SAS 
9.4 (Cary, NC).  
 
Results 
 The demographic and baseline health characteristics for smokers (n = 1,759), 
non-smokers (n = 1,174), and quitters (n = 183) are shown in Table 1.2. Compared with 
non-smokers, smokers have higher male proportion, younger age, and better education 
level. The majority of non-smokers are female (84.0%) and half of them have the 
occupation of housewife. The occupations of the smokers are mainly supervisor, laborer, 
and housewife. At baseline, the smokers appear to have better health status for lower SBP, 
cholesterol level, and BMI.  
 We use the g-formula to estimate the TE of smoking (20 cigarettes per day v.s. no 
smoking for 10 years) on SBP and BMI in Table 1.3. Smoking elevates SBP by 1.18 
mm-Hg and reduces BMI by 0.16 kg/m
2
. In Table 1.4, we use the parametric mediational 
g-formula to simulate the SBP at the end of 10-year follow-up under no smoking with 
BMI distributed as the BMI under no smoking, smoking 20 cigarettes per day with BMI 
distributed as the BMI under smoking 20 cigarettes per day, no smoking with BMI 
distributed as the BMI under smoking 20 cigarettes per day, and smoking 20 cigarettes 
per day with BMI distributed as the BMI under no smoking. We then estimate the rTE, 
rNDE, and rNIE of smoking on SBP mediated by BMI. The rTE, rNDE, and rNIE 
estimates are 1.18 (95 % CI: -0.68, 2.69) mm-Hg, 1.52 (95 % CI: -0.25, 2.90) mm-Hg, 
and -0.34 (95 % CI: -0.52, -0.13) mm-Hg, respectively. The directions of rNIE and rNDE 
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are different, suggesting that the seemingly protective mediated effect of smoking 
through BMI may partially mask the detrimental direct effect of smoking on SBP. 
  
Discussion 
 This is the first paper to provide a fully parametric method for causal mediation 
analysis with time-varying mediators. We develop an algorithm and corresponding SAS 
macro to use the mediational g-formula parametrically. We use the parametric approach 
to obtain estimates for the mediational g-formula by adapting the g-formula macro 
externally to build our SAS macro. Similar to the g-formula, we use Monte-Carlo 
simulation and bootstrapping methods for point and interval estimation, respectively. 
Since the estimation is an approximation of the maximum likelihood estimation, this 
estimation is asymptotically efficient provided the regression models are all correctly 
specified, while the IPW does not achieve the efficiency bound in a model where 
parametric assumptions about the weights and the MSM are correct. In addition, like 
other simulation-based methods 
39
, the approach here has the advantage of allowing for 
very flexible models such as quadratic linear models.  
 The parametric mediational g-formula provides a powerful method to investigate the 
mechanisms of an effect through time-varying mediators. Traditional techniques, 
allowing only one observation of the mediator and restricting it to variables occurring 
immediately after the exposure, inadequately capture the indirect effect when the 
exposures affect the mediators over time. One alternative approach is to estimate the 
controlled direct effect (CDE), the effect of the exposures on the outcome when fixing 
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the mediators at certain values. Obtained by applying the g-formula and specifying the 
mediators to these values, the CDE estimate provides valuable information for policy 
makers. For example, from FHS data we can provide the effect of smoking cessation 
decreasing SBP if BMI is fixed to a certain level. This is also described elaborately 
elsewhere 
40
. The effects from the meditational g-formula will, however, further allow for 
effect decomposition. 
 This study provides direct evidence for the hypothesis that “the adverse effect of 
smoking on high blood pressure is partially concealed by weight loss” 13,21. The 
concealment of the effect is partial because smoking does not decrease weight 
substantially (Table 1.3). Some studies report an effect of smoking cessation on increased 
blood pressure 
21,22
. The discrepancy with these studies might be attributed to a different 
analysis approach or simply the special characteristics of FHS participants. 
 Several limitations of this study should be noted. First, the use of rTE, rNDE, and 
rNIE, defined based on the stochastic interventions, results in different interpretations 
from the TE, NDE, and NIE 
34
. This is inevitable for causal mediation analysis with 
time-varying mediators because the NDE and NIE are not generally identified by 
empirical data in the presence of time-varying confounders, rNDE and rNIE can still 
serve as an analogue of NDE and NIE, and have the advantage that they can be verified 
by randomized controlled trial, while NDE and NIE cannot. Second, in the macro we 
have developed, the outcome can only be affected by the covariates at the most recent 
three exams because of a similar restriction of the g-formula macro that is employed for 
continuous/binary outcome types. This is not a limitation of the methodology itself, but 
only of the current implementation. The earlier covariates affect the outcome only 
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through these recent covariates. We specify the outcome variables in previous exams (i.e. 
the previous SBP values) as the time-varying covariates. Thus, the earlier covariates can 
also affect the outcome through the previous outcome variables. Third, selection bias has 
not been adjusted for here. Selection bias or truncation by death is a difficult problem for 
causal inference generally and for mediation analysis, even with only one single mediator. 
Most of the literature makes a sequential ignorability assumption that survival is 
effectively randomized conditional on the past. Under this assumption, the result can be 
interpreted as what would happen to the population if one could intervene to prevent 
death for everyone. Alternatively, one could also pursue sensitivity analysis approaches 
and there are also alternative stronger assumptions that would allow one to interpret the 
results without necessarily intervening upon death 
41, 42
. We hope to address this in future 
work but the extension of this to time-varying exposures and mediators is substantial. For 
the purposes of the illustration, we have simply focused on complete-case data and 
restricted our follow-up to ten years to partially address this selection bias. The relatively 
low proportion of loss to follow-up (< 20%) perhaps partially mitigates this problem. A 
general disadvantage of our proposed approach is that it may be particularly prone to bias 
due to model misspecification. Some misspecification may be theoretically guaranteed in 
complex longitudinal settings as considered here when the null hypothesis of no causal 
time-varying treatment effect is true, a problem known as the g-null paradox 43. The 
magnitude of bias implied by the g-null paradox is not guaranteed and, depending on the 
setting, may be large or small. For some further consideration of the g-null paradox using 
numerical examples, see Young and Tchetgen Tchtegen 
44
. The aforementioned IPW 
estimator offers an alternative method which is not subject to the g-null paradox and 
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might be used for the population estimands considered here 
45
. Finally, the analysis is 
subject to potential violation of the confounding assumptions. Future research could 
develop sensitivity analysis techniques for violations of these assumptions for our 
method. 
 
Conclusion 
 The parametric mediational g-formula serves as a powerful and useful tool for 
mediation analysis with longitudinal data. Researchers can apply our method to 
disentangle the complicated causal mechanisms arising from time-varying mediators, 
exposures, and confounders. Further issues concerning the interpretation of the 
interventional direct and indirect effects can be found in VanderWeele and Tchetgen 
Tchetgen
10
. Using this method, we provide evidence that weight change in fact partially 
conceals the detrimental effect of cigarette smoking on blood pressure.  
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Table 1.1. Summary of covariate models.  
Variable Type of model when used as 
dependent variable 
Functional form when 
used as predictor 
Non-modifiable   
Gender Not predicted Indicator 
Age Not predicted Quadratic linear 
Height Not predicted Quadratic linear 
Education level Not predicted Six categories
a 
Occupation Not predicted Six categories
a
 
Marital status Not predicted Three categories
b
 
Baseline smoking Not predicted Three categories
b
 
Modifiable   
SBP Linear Quadratic linear 
Smoking Logistic then log-linear
c 
Quadratic linear 
Cholesterol Linear Quadratic linear 
Anti-hypertension 
drug 
Linear Three categories
b
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a
 Education level categories are ≤ 8th grade, some high school, high school graduate, 
some college, college graduate, and post-graduate. Occupation categories are 
executive/supervisory, technical, laborer, clerical, sales, and housewife. 
b
Marital status categories are single, married, and divorce or widowed. Baseline smoking 
are smoking, not smoking, and quitting. Anti-hypertension drug are regular use, not use, 
and sporadic use. 
c
zero-continuous variables such as cigarettes per day are predicted in two stages, first a 
logistic regression on an indicator of whether the variable is nonzero and then a linear 
regression of the log of the nonzero values. 
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Table 1.2. Baseline characteristics of eligible participants grouped by former 
smoking status. 
Characteristic Quitters Non-smokers Smokers p-value 
(n = 183) (n = 1,174) (n = 1,759)  
Male (%)    128 (69.9)     188 (16.0)    1049 (59.6)  <0.001 
Age, year  
(Mean (SD)) 
 50.10 (8.49)  48.90 (8.49)  45.87 (7.96) <0.001 
SBP, mmHg  
(Mean (SD))
 
 
128.53 (17.79) 131.64 (21.54) 125.97 (17.98) <0.001 
BMI  
(Mean (SD))
 
 
 25.92 (3.51)  26.22 (4.22)  25.16 (3.68) <0.001 
Chol  
(Mean (SD)) 
233.89 (44.08) 232.18 (44.75) 227.54 (42.97) 0.008 
Height  
(Mean (SD))
 
 
 66.41 (3.46)  62.93 (3.20)  65.46 (3.42) <0.001 
Education (%)    0.019 
<High school     65 (35.5)     507 (43.2)     675 (38.4)  
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High school     64 (35.0)     420 (35.8)     707 (40.2)   
College or higher     51 (27.9)     227 (19.3)     350 (19.9)   
Missing      3 ( 1.6)      20 ( 1.7)      27 ( 1.5)   
Work (%)    <0.001 
Supervisory     58 (31.7)     156 (13.3)     419 (23.8)   
Technical     20 (10.9)      31 ( 2.6)     130 ( 7.4)   
Laborer     48 (26.2)     238 (20.3)     517 (29.4)   
Clerical     12 ( 6.6)      76 ( 6.5)     109 ( 6.2)   
Sales      8 ( 4.4)      19 ( 1.6)      91 ( 5.2)   
Housewife     36 (19.7)     647 (55.1)     478 (27.2)   
Missing      1 ( 0.5)       7 ( 0.6)      15 ( 0.9)   
Marital (%)    <0.001 
Married    163 (89.1)     935 (79.6)    1580 (89.8)   
Single     10 ( 5.5)     145 (12.4)     105 ( 6.0)   
Divorced     10 ( 5.5)      94 ( 8.0)      74 ( 4.2)   
SBP: systolic blood pressure; BMI: body mass index; Chol: cholesterol level;  
No one use the anti-hypertensive drugs at the beginning.   
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Table 1.3. Estimates of the total effect of smoking 20 cigarettes per day for 10 years 
(compared with no smoking) on SBP and BMI.  
Intervention SBP  
(mm-Hg) 
Change of SBP  
(95% CI) 
BMI  
(kg/m
2
) 
Change of BMI  
(95% CI) 
No intervention 136.22 0.52 (-0.08, 1.02) 25.83 -0.04 (-0.20, 0.05) 
no smoking  135.70 reference 25.87 reference 
20 cigarettes/day 136.88 1.18 (-1.01, 3.14) 25.71 -0.16 (-0.37, 0.02) 
SBP: systolic blood pressure; BMI: body mass index; CI: confident interval; 
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Table 1.4. Randomly interventional analogue of total effect, of natural direct effect, 
and of natural indirect effect for the effect of smoking 20 cigarettes per day for 10 
years (compared with no smoking) on SBP, mediated by BMI change over time. 
 Estimate 95% CI 
E[Y0G0] 135.691 134.93, 137.11 
E[Y1G0] 137.211 135.76, 138.80 
E[Y0G1] 135.336 134.57, 136.69 
E[Y1G1] 136.874 135.64, 138.37 
rTE 1.18 -0.68, 2.69 
rNDE 1.52 -0.25, 2.90 
rNIE -0.34 -0.52, -0.13 
rTE: randomly interventional analogue of total effect; rNDE: randomly interventional 
analogue of natural direct effect; rNIE: randomly interventional analogue of natural 
indirect effect; CI: confident interval; E[Y0G0], E[Y1G0], E[Y0G1], and E[Y1G1] 
represent “no smoking with BMI distributed as the BMI under no smoking”, “smoking 20 
cigarettes per day with BMI distributed as the BMI under no smoking”, “no smoking 
with BMI distributed as the BMI under smoking 20 cigarettes per day”, and “smoking 20 
cigarettes per day with BMI distributed as the BMI under smoking 20 cigarettes per day”, 
respectively. 
  
35 
 
Figure 1.1.Simple model for mediation analysis. 
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Figure 1.2.Mediation analysis with a mediator-outcome confounder L that is 
affected by exposure. 
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Figure 1.3. Time-varying mediation with ordering of variables of A(t), M(t), L(t), for t = 0 to T-1. 
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Abstract  
This study proposes an approach to conduct mediation analysis for survival data 
with time-varying exposures, mediators, and confounders. We identify the direct and 
indirect effects through a survival mediational g-formula and provide the required 
assumptions. We also provide a feasible parametric approach along with an algorithm 
and software to estimate these effects. We apply this method to analyze the Framingham 
Heart Study data to investigate the causal mechanism of smoking on mortality. The risk 
ratio of smoking 30 cigarettes per day for ten years compared with no smoking on 
mortality is 2.34 (95 % CI = (1.44, 3.70)). Among the effect, 7.91 % is mediated by 
coronary artery disease. The survival mediational g-formula constitutes a powerful tool 
for conducting mediation analysis with longitudinal data. 
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Introduction 
Background 
In decomposing the total effect into direct and indirect effects, mediation analysis is 
essential for investigating pathways or mechanisms in epidemiology and the social 
sciences. Causal mediation analysis defines both direct and indirect effects based on 
counterfactual models, extending traditional mediation analysis to settings involving 
nonlinearities and interaction 
1,2
. Numerous methodological approaches based on causal 
mediation analysis have been developed in recent years allowing different outcome scales, 
including the risk difference, the odds ratio, and the time-to-event data 
3-8
. Most of the 
approaches mentioned above only consider one exposure along with one mediator. When 
conducting causal mediation analysis with longitudinal data, only one single exposure 
and mediator ignore the exposures or mediators at other time-points, thus eliminating 
large quantities of valuable information.  
VanderWeele and Tchetgen Tchetgen have proposed the mediational g-formula to 
address the methodological challenges of causal mediation analysis with time-varying 
mediators 
9
. This method decomposes the total effect into newly defined direct and 
indirect effects and therefore moves beyond the limitations of a single exposure and a 
single mediator. Using this method, time-varying confounders are also adjusted for. Lin 
et al. proposed a parametric g-computation approach with an available SAS macro to 
implement this method for the Framingham Heart Study (FHS), investigating the 
mechanism of smoking on systolic blood pressure mediated by weight change over time 
10
. The mediational g-formula allows the outcome of interest as a variable at the end of 
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follow up. For a survival outcome, Zheng and van der Laan have provided a similar 
approach with time-varying mediators, one fixed exposure, and baseline confounders 
11
.  
 In the current study, we extend the mediational g-formula and Zheng’s and van der 
Laan's technique to offer a generalized setting with survival outcome and time-varying 
mediators, exposures, and confounders. We define and identify the direct and indirect 
effects, propose a parametric approach to estimate these effects, and provide an algorithm 
as well as a corresponding Statistical Analysis System (SAS) macro for practical 
application. We then apply this method to the FHS data to investigate the effect of 
smoking on mortality mediated by coronary artery disease (CAD). 
 The paper is organized as follows: Section 1.2 describes the case study, and section 
2 introduces the notations and definitions of the direct and indirect effects of interest. 
Section 3 presents the non-parametric identification of the direct and indirect effects, and 
the required assumptions. Section 3 also shows that our formula reduces to the formula 
provided by Zheng and van der Laan 
11
 when both an exposure and confounders are not 
time-varying. Our approach however is applicable with time-varying exposures and 
confounders. A feasible parametric approach along with an algorithm and software are 
also provided. Section 4 describes the analytical procedure and provides the estimation 
results for the FHS data. Section 5 concludes by discussing the strengths and limitations 
of the study.  
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Case study for Framingham dataset: smoking, coronary artery disease, and overall 
mortality 
 Using the FHS data as an example, our main focus is the effect of smoking on 
mortality mediated by coronary artery disease (CAD). In the FHS data, smoking and 
CAD status vary over time. We obtain the estimates of this effect by applying our method 
to the FHS data and demonstrate the applications of mediation analysis with time-varying 
covariates (including mediators, exposures, and confounders). We treat smoking status 
and CAD as exposures and mediators of interest, respectively. 
 
Notations and definitions 
Notations 
 Consider that the exposures, mediators, confounders, and survival outcomes vary 
over time in longitudinal data with 1 to T measurement. Let (A(1), ..., A(T)), (M(1), ..., 
M(T)), (L(1), ..., L(T)), and (S(1), ..., S(T)) denote values of time-varying exposures, 
mediators, confounders, and survival outcomes at periods 1,..., T, with initial baseline 
confounders, V. The survival outcome at the end of follow up (S(T)) is the outcome of 
interest. S(t) = 1 indicates survival at time t; and S(t) = 0 indicates death at time t. The 
causal relationship among these variables is demonstrated in Figure 2.1.  
 For any variable W and value w, let W(t1:t2) = (W(t1), W(t1+1), ..., W(t2)) and w(t1:t2) 
= (w(t1), w(t1+1), ..., w(t2)), while t1 and t2 are all positive integers and t1 ＜ t2. Let 
A(1:T) = a(1:T) and A(1:T) = a(1:T)* denote two hypothetical intervention statuses, 
exposure and non-exposure, respectively. Let S(t)a(1:t)m(1:t) be the counterfactual value of 
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S(t), given the previous exposures A(1:t) are set to a(1:t) and the previous mediators 
M(1:t) are set to m(1:t). Let S(t)a(1:t)m(1:t)s(1:t-1) be the counterfactual value of S(t), given the 
previous exposures A(1:t) are set to a(1:t), the previous mediators M(1:t) are set to m(1:t), 
and S(1:t-1) are set to s(1:t-1). Here we are conceiving an intervention on survival. 
Another way forward for this problem is addressed by principal stratification 
12,13
, but this 
is difficult to the context of mediation. So we assume that the intervention on survival is 
possible as does prior literature. Let M(t)a(1:t) and S(t)a(1:t) be the counterfactual value of 
M(t) and S(t), respectively, given A(1:t) are set to a(1:t). Let G(t)a(1:t) denote a random 
draw from the distribution of the mediator M(t)a(1:t). Let M(t)a(1:t)m(1:t)s(1:t-1) be the 
counterfactual value of M(t), given the previous exposures, A(1:t), are set to a(1:t), the 
previous mediators, M(1:t-1), are set to m(1:t-1), and S(1:t-1) is set to s(1:t-1). Since the 
S(t) is the survival variable, when S(t) = 0, the following survival variables (i.e. S(k), 
while k∈ {t+1, t+2, ..., T}) are all equal to zero, and the following variables other than 
S(k) (i.e. A(k), M(k), L(k), while k∈ {t+1, t+2, ..., T}) are all undefined. In addition, we 
also make the consistency assumption 
6,14,15
. Under this assumption, S(t)a(1:t) = S(t) and 
M(t)a(1:t) = M(t) given A(1:t) = a(1:t); S(t)a(1:t)m(1:t) = S(t) given A(1:t) = a(1:t) and M(1:t) = 
m(1:t); S(t)a(1:t)m(1:t)s(1:t-1) = S(t) given A(1:t) = a(1:t), M(1:t) = m(1:t), and S(t-1) = s(t-1); 
and M(t)a(1:t)m(1:t-1)s(1:t-1) = M(t), given A(1:t) = a(1:t), M(1:t-1) = m(1:t-1), and S(t-1) = 
s(t-1).  
 For convenience of the notation in Section 2.2 and Section 3, we define M(t)*, G(t)*, 
and S(t)* sequentially. When time = 1, M(1)* is defined as M(1)a(1)*, G(1)* as the 
random draw of M(1)*, and S(1)* as S(1)a(1), G(1)*. When time = 2, M(2)* is defined as 
M(2)a(1:2)*,G(1)*,S(1)*, G(2)* as the random draw of M(2)*, and S(2)* as S(2)a(1:2),G(1:2)*,S(1)*. 
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We continue this definition process iteratively. For time = t, M(t)* is defined as 
M(t)a(1:t)*,G(1:t-1)*,S(1:t-1)*, G(t)* as the random draw of M(t)*, and S(t)* as S(t)a(1:t), 
G(1:t)*,S(1:t-1)*. To conveniently illustrate the distinction of the new definition from the 
traditional definition, we introduce M(t)** and S(t)** by a similar definition process as 
M(t)* and S(t)*. When time = 1, M(1)** is defined as M(1)a(1)* (which is exactly equal to 
M(1)*), and S(1)** as S(1)a(1), M(1)** (which replace the G(1)* by M(1)* in S(1)*). When 
time = 2, M(2)** is defined as M(2)a(1:2)*,M(1)**,S(1)**, and S(2)** as S(2)a(1:2),M(1:2)**,S(1)**. 
We again repeat this definition process. For time = t, M(t)** is defined as 
M(t)a(1:t)*,M(1:t-1)**,S(1:t-1)**, and S(t)** as S(t)a(1:t), M(1:t)**,S(1:t-1)**. Compared with S(t)*, we 
define S(t)** by using M(t)** directly, rather than its random draw G(t)**. 
 Since M(t) is undefined when S(t-1) = 0, under the counterfactual model, M(t)s(t-1)=0 
is also undefined. Consequently, S(t)m(t),s(t-1)=1 is undefined when m(t) is undefined. Since 
S(t) is always equal to zero when S(t-1) = 0, S(t)m(t),s(t-1)=0 is always equal to zero even 
when m(t) is undefined. M(t)* is undefined if and only if S(t-1)* = 0. Therefore, S(t)* is 
still defined even when M(t)* is undefined since in that condition, S(t-1)* should be zero, 
leading to S(t)* = 0. Similarly, S(t)** is always defined, too. 
 
Definitions of mediation parameter and the direct and indirect effects 
 Aiming to investigate the extent of the effect of exposures over time (A(1:T)) on the 
survival outcome at the end of follow up (S(T)), through mediators over time (M(1:T)), 
mediation analysis decomposes the overall effect into a direct effect (the effect not 
through the mediators) and an indirect effect (the effect through the mediators). The 
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direct and indirect effects are traditionally represented by the natural direct effect (NDE) 
and the natural indirect effect (NIE), respectively; NDE and NIE are mathematically 
defined as E[S(T)a(1:T),M(1:T)a∗  - S(T)a(1:T)∗,M(1:T)a(1:T)∗ |v] and E[S(T)a(1:T),M(1:T)a(1:T)  - 
S(T)a(1:T),M(1:T)a(1:T)∗ ], respectively 
1,2,6
. For simplicity of expression, we define the 
mediation parameter Φ(a(1:T), a(1:T)*) as E[S(T)a(1:T),M(1:T)a(1:T)∗]. Thus, we can rewrite 
the NDE and NIE as Φ(a(1:T), a(1:T)*) - Φ(a(1:T)*, a(1:T)*) and Φ(a(1:T), a(1:T)) - 
Φ(a(1:T), a(1:T)*), respectively. This definition of NIE captures all effects of A(1:T) on 
S(T) through M(1:T).  
The direct and indirect effects can also be represented by interventional direct effect 
(IDE) and interventional indirect effect (IIE), of which the mediation parameter is 
defined as E[S(T)a(1:T),G(1:T)a(1:T)∗]. In some literatures, IDE and IIE were also named 
randomly interventional analogues of natural direct effect and of natural indirect effect, 
respectively 
9,10,16
. When the time-varying confounders exist, both IDE and IIE can be 
identified by the empirical dataset, but NDE and NIE cannot. 
The definition of NDE and NIE presents a major problem for individuals when the 
exposures benefit the survival status at time T-1, not through the mediators 
(mathematically expressed as S(T − 1)a(1:T),M(1:T−1)a(1:T)∗  = 1 and 
S(T − 1)a(1:T)∗,M(1:T−1)a(1:T)∗  = 0). Based on this mathematical expression, M(1:T)a(1:T)* 
(defined as M(1: T)a(1:T)∗,M(1:T−1)a(1:T)∗,S(T−1)a(1:T)∗,M(1:T−1)a(1:T)∗ ) is equal to 
M(1: T)a(1:T)∗,M(1:T−1)a(1:T)∗,s(T−1)=0, which is undefined. Consequently, the mediation 
parameter Φ(a(1:T), a(1:T)*) ( = S(T)a(1:T),M(1:T)a(1:T)∗  = 
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S(T)a(1:T),M(1:T)a(1:T)∗,𝑆(1:𝑇−1)a(1:T),M(1:T)a(1:T)∗
 by definition) is also undefined. In addition, 
NDE and NIE, which are both defined by Φ(a(1:T), a(1:T)*), are also undefined. Both 
IDE and IIE are also undefined since G is a random draw of M.  
One way to address the undefined NDE and NIE (as well as IDE and IIE) is 
changing the definition of the mediation parameter (Zheng and van der Laan, 2012). In 
Section 2.1, we have shown that both S(t)* is always defined. The alternative mediation 
parameter, Ψ(a(1:T), a(1:T)*), is defined as E[S(T)*]. IDE and IIE are then defined as 
Ψ(a(1:T), a(1:T)*) - Ψ(a(1:T)*, a(1:T)*) and Ψ(a(1:T), a(1:T)) - Ψ(a(1:T), a(1:T)*), 
respectively. Since S(t)** is also always defined, we can use the E[S(T)**] to define 
mediation parameter, as well as NDE and NIE. Since time-varying confounders cannot be 
ignored in settings with time-varying exposures and mediators, we consider E[S(T)*] 
rather than E[S(T)**] to define mediation parameter Ψ(a(1:T), a(1:T)*) and try to 
identify and estimate IDE and IIE in the current study.  
These definitions (by S(T)* or S(T)**) are based on the path-specific effect 
9,11,17
. 
Under the traditional definition, an indirect effect consists of two groups of path-specific 
effects: first, the path of exposures affecting the mediators through earlier survival history, 
and second, the path of exposures affecting the mediators not through earlier survival 
history. Under our definition for the alternative mediation parameter (Ψ(a(1:T), a(1:T)*)), 
the indirect effect includes the second path-specific effect, and the first path-specific 
effect is included in the direct effect.  
 We now illustrate the distinction between traditional definition and our definition by 
taking the simplest setting as an example: given T = 2, and V, A(2), L(1), and L(2) are all 
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empty (Figure 2.2). Since the mediation parameter defined by E[S(T)*] or E[S(T)**] 
captures the similar path. For heuristic concerning the effects, we consider E[S(t)**] as 
an analogue of E[S(T)*]. According to traditional definition, NIE includes (a) 
A→M(2)→S(2), (b) A→M(1) →M(2) →S(2), (c) A→M(1) →S(1) →M(2) →S(2), (d) 
A→M(1)  →S(1)  →S(2), and (e) A→M(1)  →S(2); NDE includes (a)A→S(1)→S(2), 
(b)A→S(1)→M(2)→S(2), and (c)A→S(2). From the eight possible path-specific effects, 
A→S(1)→M(2)→S(2) is traditionally included as part of NIE since M(2) is involved. 
Under our definition, A→S(1)→M(2)→S(2) is included in NDE since the exposure affects 
survival history (S(1)) first, not through the earlier mediator (M(1)). The path 
(A → S(1) → M(2) → S(2)) can be measured by 
E[ S(2)𝑎,M(1)a∗,𝑆(1)a,M(1)a∗ ,M(2)a∗,M(1)a∗,𝑆(1)𝑎,M(1)a∗
] - 
E[S(2)𝑎,M(1)a∗,𝑆(1)a,M(1)a∗ ,M(2)a∗,M(1)a∗,𝑆(1)𝑎∗,M(1)a∗
] (i.e., E[S(2)**] - Φ(a,a*); here, we use 
E[S(2)**] rather than E[S(2)*] for heuristic simplicity). When exposure affects survival 
status at time 1 beneficially (mathematically expressed as (S(1)a,M(1)a∗, S(1)a*) = (1,0)), 
the Φ(a,a*) (= E[S(2)𝑎,M(1)a∗,s(1)=1,M(2)a∗,M(1)a∗,𝑆(1)=0]) is undefined, and consequently, the 
path, A→S(1)→M(2)→S(2), is undefined. On the other hand, when exposure has 
monotonically harmful effect on survival status at time 1 (mathematically expressed as 
(S(1)a,M(1)a∗, S(1)a*) ∈ {(1,1), (0,0), (0,1)}), the path is always equal to zero (when 
S(1)a,M(1)a∗  = 0, E[S(2)**] = E[S(2)𝑎,M(1)a∗,s(1)=0,M(2)a∗,M(1)a∗,𝑆(1)=0] = 0 and Φ(a,a*) = 
E[S(2)𝑎,M(1)a∗,s(1)=0,M(2)a∗,M(1)a∗,𝑆(1)𝑎∗,M(1)a∗
] = 0; when S(1)a,M(1)a∗  = 1 and S(1)a* = 1, 
E[S(2)**] and Φ(a,a*) are all equal to E[ S(2)𝑎,M(1)a∗,s(1)=1,M(2)a∗,M(1)a∗,𝑆(1)=1 ]). In 
conclusion, the difference between the traditional and alternative mediation parameters is 
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always undefined or zero. Thus, the path-specific effect is a reasonable alternative 
definition for the direct and indirect effects.  
 
Identification and estimation of survival mediational g-formula 
Assumptions and identification for survival mediational g-formula 
 For identifying the mediation parameter, Ψ(a(1:T), a(1:T)*), we should make the 
following four, sequential no unmeasured confounding assumptions for t = 1, 2, ..., T: 
1. S(T)a(1:t),m(1:t),s(1:t-1)=1,G(t+1:T)*,S(t:T-1)* ⊥ A(t)|v,A(1:t-1)=a(1:t-1), M(1:t-1)=m(1:t-1), 
L(1:t-1),S(1:t-1)*=1, G(1:t)* = m(1:t) (no unmeasured exposure-outcome confounding 
conditional on the past covariates, while ⊥ indicates independence) 
2. S(T)a(1:t), m(1:t), s(1:t-1)=1,G(t+1:T)*,S(t:T-1)*⊥M(t)|v, A(1:t)=a(1:t), M(1:t-1)=m(1:t-1), L(1:t-1), 
S(1:t-1)*=1, G(1:t)*=m(1:t) (no unmeasured mediator-outcome confounding conditional 
on the past covariates) 
3. M(t) a(1:t)*,m(1:t-1),s(1:t-1)=1 ⊥ S(t-1)|v, A(1:t-1), M(1:t-1), L(1:t-1), S(1:t-2)=1 (no 
unmeasured mediator-previous survival confounding conditional on the past covariates) 
4. M(t) a(1:t)*,m(1:t-1),s(1:t-1)=1⊥A(t)|A(1:t-1),M(1:t-1),L(1:t-1),S(1:t-1)=1,v (no unmeasured 
exposure-mediator confounding conditional on the past covariates) 
 
 It is worth noting that an unmeasured confounder of survival statuses at different 
time points is allowed. None of the assumptions (even assumption 3) will be violated. We 
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will illustrate this situation in Appendix 2.4. Under the four assumptions, the mediation 
parameter Ψ(a(1:T), a(1:T)*) can be identified as Q(a(1:T), a(1:T)*) 
= 
∑ ∑ ∏ E[S(t)|a(1: t), m(1: t), l(1: t), S(t − 1) = 1, v]Tt=1 ×l(1:T)v,m(1:T)
∏ P(l(t)|a(1: t), m(1: t), l(1: t − 1), S(t − 1) = 1, v)T−1t=1 ×
∑ ∏ Pr(m(t)|a∗(1: t), m(1: t − 1), l′(1: t − 1), S(1: t − 1) = 1, v) ×Tt=1l′(1:T−1)
Pr(l′(t − 1)|a∗(1: t − 1), m(1: t − 1), l′(1: t − 2), S(1: t − 2) = 1, v) Pr (v) 
 
The Q(a(1:T), a(1:T)*) can also be expressed by the counting process notation, N(t), 
and the continuous time-varying mediators and confounders as follows. 
Q(a(1:T), a(1:T)*) 
= 
∫ ∏ E[1 − N(t)|a(1: t), m(1: t), l(1: t), N(t − 1) = 0, v]Tt=1 ×m(1:T),l(1:T)
∏ 𝑓𝐿(𝑡)(l(t)|a(1: t), m(1: t), l(1: t − 1), N(t − 1) = 0, v)
T−1
t=1 dl(1: T) ×
∫ ∏ 𝑓𝑀(𝑡)(m(t)|a
∗(1: t), m(1: t − 1), l′(1: t − 1), N(1: t − 1) = 0, v) ×Tt=1l′(1:T−1)
𝑓𝐿′(𝑡−1)(l
′(t − 1)|a∗(1: t − 1), m(1: t − 1), l′(1: t − 2), N(1: t − 2) = 0, v)dm(1: T)dl′(1: T −
1) 
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 The proof is provided in Appendix 2.1 and 2.3. We refer to this final expression 
Q(a(1:T), a(1:T)*) as the survival mediational g-formula (sMGF). Consequently, the IDE 
and IIE can be identified non-parametrically by the following equations: 
 
IDE = Q(a(1:T), a(1:T)*) - Q(a(1:T)*, a(1:T)*) 
IIE = Q(a(1:T), a(1:T)) - Q(a(1:T), a(1:T)*) 
 
 Intuitively, the first part 
(∑ ∑ ∏ E[S(t)|a(1: t), m(1: t), l(1: t), S(t − 1) = 1, v]Tt=1 ×l(1:T)m(1:T)
∏ P(l(t)|a(1: t), m(1: t), l(1: t − 1), S(t − 1) = 1, v)T−1t=1 ) is the g-formula when outcome 
is a survival variable without censoring (Robins, 1982; Robins et. al., 2004; Taubulin et. 
al. 2009). The second part 
(∑ ∏ Pr(m(t)|a∗(1: t), m(1: t − 1), l′(1: t − 1), S(1: t − 1) = 1, v) ×Tt=1l′(1:T−1)
Pr(l′(t − 1)|a∗(1: t − 1), m(1: t − 1), l′(1: t − 2), S(1: t − 2) = 1, v)) is the joint 
distribution of mediators, M(1:T), given all exposures are set to a(1:T)* for survivors.  
 
 When mediators are empty, the survival mediational g-formula reduces to the 
following form: 
E[S(T)a(1:T)]= 
∑ ∏ E[S(t)|a(1: t), l(1: t), S(t − 1) = 1, v]
T
t=1l(1:T)
× ∏ P(l(t)|a(1: t), l(1: t − 1), S(t − 1) = 1, v)
T−1
t=1
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which is the standard g-formula. Thus we can conclude that the survival mediational 
g-formula is a generalized form of g-formula, similar to the mediational g-formula 
9
.  
 When S(T-1) is always equal to one, this expression reduces to  
 
∑ ∑ E[S(T)|a(1: T), m(1: T), l(1: T), v]
l(1:T)m(1:T)
× ∏ P(l(t)|a(1: t), m(1: t), l(1: t − 1), v)
T−1
t=1
× ∑ ∏ Pr(m(t)|a∗(1: t), m(1: t − 1), l′(1: t − 1), v)
T
t=1l′(1:T−1)
× Pr(l′(t − 1)|a∗(1: t − 1), m(1: t − 1), l′(1: t − 2), v) 
  
which is the exact mediational g-formula provided by VanderWeele and Tchetgen 
Tchetgen's work 
9
, given that the outcome of interest (denoted as Y) is survival status at 
the end of follow up (S(T)).  
 If neither the confounders and exposure are not time-varying (i.e. A(2:T) and L(1:T) 
are empty) (Figure 2.3), the survival mediational g-formula reduces to  
 
∑ ∏ E[S(t)|a, m(1: t), S(t − 1) = 1, v]
T
t=1m(1:T)
× Pr(m(t)|a∗, m(1: t − 1), S(t − 1) = 1, v) 
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which is exactly equal to Zheng’s and van der Laan's expression (equation 6 and equation 
24) 
11
. However, our survival mediational g-formula can still be used, unlike the approach 
of Zheng and van der Laan, even if the exposures and confounders are time-varying.  
Furthermore, under the monotonicity assumption: 
 
S(t)a,m(1:t-1) ≤ S(t)a*,m(1:t-1) for all individuals where t = 1, 2, ..., T-1, 
 
the traditional definition of mediation parameter Φ(a(1:T), a(1:T)*) can be defined and 
identified by the following expression: 
 
∑ ∏ E[S(t)|a(1: t), m(1: t), S(t − 1) = 1, v]
T
t=1m(1:T)
× Pr(m(t)|a(1: t)∗, m(1: t − 1), S(t − 1) = 1, v) 
 
 The proof is provided in Appendix 2.2. This expression is also the special case of 
the sMGF when both A(2:T) and L(1:T) are empty. In other words, given time-varying 
confounders do not exist and exposures have monotonically harmful effect on survival, 
the alternative definitions of IDE and IIE are the same as the traditional definitions of 
NDE and NIE, respectively (i.e., the difference between the traditional and alternative 
mediation parameters is equal to zero).  
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Parametric approach for survival mediational g-formula 
VanderWeele and Tchetgen Tchetgen described how to use marginal structure 
models (MSM) to estimate the mediational g-formula function 
9
, which can be inefficient 
and does not work well with continuous exposures and mediators. Lin et al have 
proposed a parametric approach for mediational g-formula 
18
. Because of strong 
modeling assumptions for outcome and all time-varying covariate modeling, a parametric 
approach can be more efficient than the MSM approach. We extend this approach to 
estimate survival mediational g-formula, developing a corresponding algorithm and a 
SAS macro. Since the survival mediational g-formula is a generalized form of the 
g-formula, we create the algorithm and the macro for the survival mediational g-formula 
based on the framework of the g-formula macro (http://www.hsph.harvard.edu/causal). 
First, we specify parametric regression models for the distribution of the time-varying 
exposures, mediators, confounders, and survival variables. For each model, we include 
former covariates as the independent variables to try to eliminate confounding and to 
ensure that the four assumptions (mentioned in Section 3.1) hold. By fitting these models 
with data, maximal likelihood estimates for all parameters can be obtained. Finally, these 
estimates are substituted for the parameters in the survival mediational g-formula, 
deriving consistent estimates for IDE and IIE based on Monte-Carlo simulation.  
The algorithm is as follows:  
(1) Fit parametric models for the observed data: for times t ≥ 1, fit parametric models for 
the joint density of the confounders, exposures, mediators, and survival status at t 
given the measured past. 
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(2) Estimate the joint distribution of time-varying mediators under time-varying exposure 
interventions a(1:T) and a(1:T)* given everyone survives. 
(2a) Set baseline (t = 1) covariates to the observed values for subject i. Recursively, 
for each time t = 1, …, T and each subject i = 1, …, n: 
(2a.i) For t ≥ 1, generate time t confounders, exposure, and mediator based on 
the estimated model coefficients of (1a) and previously generated 
covariates under the time-varying exposure intervention a(1:t-1). 
(2a.ii) Assign time t exposure under the intervention a(1:T).   
(2b) For each t = 1,…T, randomly permute the n values of the joint mediators 
assigned under intervention a(1:T) in (2a). For each t, save this permutation for 
use in (3) below (we obtain the random draw of the survivor mediator under 
exposure, G(1:T)a(1:T), s(T-1)=1, in this step). 
(2c) Repeat (2a) replacing intervention a(1:T) with a(1:T)*.   
(2d) Repeat (2b) replacing intervention a(1:T) with a(1:T)* (we obtain the random 
draw of the survivor mediator under non-exposure, G(1:T)a(1:T)*, s(T-1)=1, in this 
step). 
(3) Estimate Q(a(1:T), a(1:T)), Q(a(1:T)*, a(1:T)), Q(a(1:T), a(1:T)*) and Q(a(1:T)*, 
a(1:T)*) by repeating the following for each (a(1:T)1, a(1:T)2) = (a(1:T), a(1:T)) , 
(a(1:T), a(1:T) *), (a(1:T)*, a(1:T)), and (a(1:T)*, a(1:T)*): 
 (3a) Recursively for each time t = 1,…,T and each subject i = 1,…,n: 
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(3a.i) Repeat (2a.i) but replacing “time-varying exposure intervention a(1:T) 
through T-1’’ with the joint “time-varying exposure and mediator 
intervention (a(1:T)1, G(1: T)a(1:T)2,s(T−1)=1)’’. 
(3a.ii) Assign the time t mediator as the i
th
 component of the permuted vector 
for time t from (2b) (if a(1: T)2 = a(1:T)) or (2d) (if a(1: T)2 = 
a(1:T)*). 
(3a.iii) Assign time t exposure under the intervention a(1: T)1. 
(3b) Simulate the outcome given each of the i = 1,…,n histories based on the 
estimated model coefficients of (1b) and the histories generated in (3a). 
(3c) Estimate Q(a(1: T)1, a(1: T)2) as the mean over the n simulated outcomes in 
(3b).    
 
Estimates of the IDE and IIE are then calculated from the estimates of the four 
Q(a(1: T)1, a(1: T)2) in (3). 95% confidence intervals are calculated based on repeating 
the above algorithm in 500 bootstrap samples of the original n observations. This 
algorithm can be implemented with the mgformula macro, freely accessible with 
documentation at http://www.hsph.harvard.edu/causal/software/.  
 
Analysis of Framingham Heart Study data 
In this section, we apply the survival mediational g-formula to the Framingham 
Heart Study (FHS) dataset to investigate the causal mechanism of smoking on overall 
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mortality mediated by CAD. FHS is a longitudinal cohort study beginning in 
Framingham, Massachusetts in 1948. The original cohort consisted of 5,209 participants 
between 30 and 62 years old without any symptom of cardiovascular disease (CVD) at 
baseline. All the participants underwent examinations at the beginning of the study and 
every two years during the follow up. For each examination, potential CVD risk factors 
including socio-demographic data, lifestyle characteristics, detailed medical history, 
physical examination data(1:T), a(1:T)nd blood samples were collected. Further details 
on the design of FHS are available elsewhere 
19,20
.  
 Exam 3 is specified as the first exam and exams 1 and 2 as pre-baseline covariates to 
allow lag predictive models. To mitigate selection bias, we focus on only ten year follow 
up (i.e. exam 3 to exam 7; the total exam number T = 5) to reduce the proportion of death 
or loss to follow up. Four exclusion criteria are listed below: (1) loss to follow up during 
the period before exam 7 (the end of follow up); (2) no record at baseline on weight, 
height, smoking status, former smoking history, systolic blood pressure (SBP), or total 
cholesterol level; (3) diagnosis of diabetes, cancer, or CVD at baseline; and (4) value for 
smoking status or BMI missing more than once. After these exclusions, 3,116 
participants are eligible for analysis. For simplicity, we now refer to the original FHS 
exams 3,..., 7 as exams 1,..., 5. 
 The smoking status at all five exams, measured as self-reported average number of 
cigarettes smoked per day, are exposures of interest (A(1:5)); mortality at the end of 
follow up is the outcome of interest (S(5)); and the CAD status at all exams are the 
mediators of interest (M(1:5)). For missing smoking status for once, we carry forward the 
last observed smoking status for one exam period only. We considered "smoking 30 
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cigarettes per day" and "no smoking" at all exams as two hypothetical intervention 
statuses, A(1:T) = a(1:T) and A(1:T) = a*(1:T). Time-varying covariates L(1:T) include 
the exam number, the systolic blood pressure (mm/hg), body mass index (kg/mm), and 
the usage of antihypertensive drugs. Baseline covariates V include gender and age (years). 
 The parametric g-formula is used to estimate the total effect of smoking 30 
cigarettes per day (v.s. no smoking) on mortality at exam 5, by the g-formula SAS macro. 
The survival mediational g-formula is applied to conduct mediation analysis with 
time-varying exposures, mediators, and confounders by the mGFORMULA SAS macro. 
For conducting the survival mediational g-formula, we specify model for the distribution 
of time-varying exposures, mediators, confounders, and survival variables at each time 
point. We use current covariates and covariates at one period back (one lagged model) as 
the predictors. Specifically, for t = 1, 2, ..., 5, we regress S(t) on A(t), M(t), L(t), A(t-1), 
M(t-1), and L(t-1); regress L(t) on A(t), M(t), A(t-1), M(t-1), and L(t-1); regress M(t) on 
A(t), A(t-1), M(t-1), and L(t-1); and regress A(t) on A(t-1), M(t-1), and L(t-1). All 
analyses are conducted using SAS 9.4 (Cary, NC).  
 The mortalities among the original group, a hypothetical group if everyone did not 
smoke for 10 years, and a hypothetical group if everyone smoked 30 cigarettes per day 
for 10 years, are 4.52 %, 3.37 %, and 7.87 %, respectively (Table 2.1). The risk ratio (RR) 
is 2.34 (95 % CI = (1.44, 3.70)), which is close to the result calculated by mGFORMULA 
macro (RR = 2.30; 95 % CI = (1.36, 2.88)). In additive scale, smoking increases mortality 
by 3.96% directly not through changing CAD, and by 0.34 % through changing CAD. 
The proportion of the total effect explained by the mediation of CAD is 7.91 % (95 % CI 
= (1.36, 19.32)) (Table 2.2). 
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Discussion 
 This is the first paper providing a generalized framework for causal mediation 
analysis with a survival outcome and with time-varying exposures, mediators, and 
confounders. We provide identification for the direct and indirect effects and the required 
assumptions, using a parametric approach for the point and interval estimation. Based on 
the g-formula macro, we have developed a feasible algorithm and a mGFORMULA SAS 
macro, which can also be used for a continuous or binary outcome 
9,10
. Similar to the 
g-formula macro, we use the Monte-Carlo simulation and bootstrapping for point and 
interval estimation, respectively. Since the estimates approximate maximal likelihood 
estimates, the efficiency of this estimation may be better than the IPW estimation 
provided the regression models are all correctly specified. Like other simulation-based 
methods 
21
, our approach has the advantage of allowing for very flexible models, such as 
quadratic model.  
 The survival mediational g-formula is currently the only method for investigating 
the mechanisms of an effect on a survival outcome with time-varying exposures, 
mediators, and confounders. Under traditional techniques for causal mediation analysis 
with survival outcome, only one mediator is allowed, and this mediator should occur 
immediately after the exposure to ensure that the identification assumption holds. Thus 
traditional techniques do not adequately capture the indirect effect given that the 
mediators vary over time 
22,23
. When both the exposure and confounders are fixed, our 
formula also reduces to Zheng’s and van der Laan’s formula 11, but our formula can be 
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used more generally, in addition to the mediators, even when the exposures and 
confounders vary over time. 
 Several limitations of this study should be noted. First, our path-specific definition is 
different from the traditional definition for direct and indirect effect. This is inevitable for 
causal mediation analysis with time-varying mediators because the NDE/NIE (as well as 
IDE/IIE) cannot be defined. Because the difference of traditional and alternative 
definitions is undefined or zero, it is reasonable to use the alternative definition. Second, 
the outcome only focuses on survival probability at the end of follow up. Extending the 
outcome model to different survival models such as the Cox proportional hazard model 
or the accelerated failure time model should be developed for future studies. Third, the 
non-ignorable drop-out has not been adjusted for here. We restricted our follow up to ten 
years to partially address this selection bias. The relatively low proportion of loss to 
follow up (< 20%) perhaps partially mitigates this problem. Our method is also sensitive 
to the violation of model misspecification, which is the trade-off in obtaining efficient 
estimates with a parametric approach. However, in our approach, the allowance for using 
very flexible models (including splines) mitigates this issue. Finally, the analysis is 
subject to potential violation of the confounding assumptions. Future research could 
develop sensitivity analysis techniques for violation of these assumptions. 
 
Conclusion 
 The survival mediational g-formula serves as a powerful and useful tool for 
mediation analysis with longitudinal data. When the outcome of interest is survival 
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variable, researchers can apply our method to disentangle the complicated causal 
mechanisms arising from time-varying mediators, exposures, and confounders. 
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Figure 2.1. Time-varying mediation with variables of A(t), M(t), L(t), and S(t), for t 
= 1 to T. 
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Figure 2.2. Simple model for survival mediation analysis with fixed exposure and 
time-varying mediators with 2 timepoints. 
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Figure 2.3. Simple model for survival mediation analysis with fixed exposure and 
time-varying mediators. 
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Table 2.1. Estimates of the overall effect of smoking 30 cigarettes per day for 10 
year (compared with no smoking) on mortality.  
Intervention Mortality  
(%) 
Difference 95% CI Ratio 95% CI 
No intervention 4.52 1.15 0.58, 2.09 1.34 1.16, 1.69 
No smoking  3.37 Ref.  Ref.  
30 cigarettes/day 7.87 4.90 1.59, 8.18 2.34 1.44, 3.70 
CI: confident interval. 
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Table 2.2. Mediation analysis for the effect of smoking 30 cigarettes per day for 10 
years (compared with no smoking) on overall mortality, mediated by cardiovascular 
disease. 
 Coronary disease 
 Estimate 95% CI 
Additive scale   
 Total effect 4.3 1.37, 6.30 
 Direct effect 3.96 1.22, 6.06 
 Indirect effect 0.34 0.05, 0.96 
Multiplicative scale   
 Total effect 2.30 1.36, 2.88 
 Direct effect 2.20 1.33, 2.70 
 Indirect effect 1.05 1.01, 1.12 
Proportion mediated (%) 7.91 1.36, 19.32 
CI: confident interval. 
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Abstract 
 Standard causal mediation analysis decomposes the total effect into a direct effect 
and an indirect effect in settings with only one single mediator. Under the settings with 
multiple mediators, all mediators are often treated as one single block of mediators. The 
effect mediated by a certain combination of mediators, i.e. path-specific effect (PSE), is 
not always identifiable without making strong assumptions. In this paper, the authors 
propose a method, defining a randomly interventional analogue of PSE (rPSE), which can 
always be non-parametrically identified under assumptions of no unmeasured 
confounding. This method also allows settings with mediators dependent on each other, 
interaction, and mediator-outcome confounders which are affected by exposure. In 
addition, under linearity and no-interaction, our method has the same form of traditional 
path analysis for PSE. Furthermore, under single mediator without a mediator-outcome 
confounder affected by exposure, it also has the same form of the results of causal 
mediation analysis. We also provide SAS code for settings of linear regression with 
exposure-mediator interaction and perform analysis in Framingham Heart Study dataset, 
investigating the mechanism of smoking on systolic blood pressure mediated by both 
cholesterol and body weight. Allowing decomposition of total effect into several rPSEs, 
our method contributes to investigation of complicated causal mechanisms in settings 
with multiple mediators. 
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Introduction 
 Mediation analysis is a technique to decompose the total effect of an exposure on an 
outcome into a direct effect (the effect not through a mediator) and an indirect effect (the 
effect through a mediator). Causal mediation analysis, defining both direct and indirect 
effects based on counterfactual models, extends mediation analysis to settings with 
nonlinearity and interaction 
1-3
. Numerous methodological techniques based on causal 
mediation analysis have been proposed recently, allowing different outcome scales, 
including additive, multiplicative, odds ratio scales, and other nonlinear models for time 
to event data 
3-11
. Most of the above techniques only consider one mediator. Under 
settings with multiple mediators, several approaches are available corresponding to 
different scientific questions. To evaluate the indirect effect mediated by all mediators, 
VanderWeele and Vansteelandt have proposed a regression-based method and a 
weighting method to estimate the direct and indirect effects mediated by all mediators at 
once 
12
. To evaluate the effect mediated by a certain combination of mediators, called 
path-specific effect (PSE) 
13
, VanderWeele et al and Avin et al have developed methods 
to identify part of PSEs non-parametrically by empirical dataset 
12,13
. However, for 
identification of all types of PSEs, strong assumptions such as linear structural equation 
model (SEM), no mediator affected by other mediator, or cross-world exchangeability are 
required 
14-16
. Assuming normal distribution for cross-world counterfactual model as well 
as no time-varying confounding, Daniel et al also proposed a sensitivity analysis 
technique to estimate the bounds of each PSE 
15
. 
 Recently, alternative definitions of direct and indirect effects, i.e. randomly 
interventional analogues of natural direct effect (rNDE) and of natural indirect effect 
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(rNIE), have been used for settings with time-varying confounders 
9,11,17
. The definition 
was also extended to longitudinal settings with time-varying exposures, mediators, and 
confounders 
18-21
. In this study, we extend the definitions of rNDE and rNIE to address 
the identification problem of PSEs in settings with multiple mediators. We first describe 
the notation and definitions of randomly interventional analogues of path-specific effects 
(rPSEs), present the non-parametric identification along with the required assumptions, 
and show the relation to the existing methods including path analysis and causal 
mediation analysis. We also provide SAS code for settings of linear regression with 
exposure-mediator interaction, using Framingham Heart Study dataset to investigate the 
mechanisms of smoking behavior on systolic blood pressure mediated by cholesterol 
level and weight change as example. Finally, we conclude by discussing the strengths and 
limitations of our method. 
 
Notation and review of standard causal mediation analysis in a setting with two 
mediators 
Notation and review for counterfactual models 
 Consider a setting with one exposure, one outcome, two mediators, two 
mediator-outcome confounders, and one baseline confounder as in Figure 3.1. Let A, Y, 
and V denote the exposure, outcome, and baseline confounders, respectively; M1 and M2 
denote the first and second mediators, respectively. L1 denotes the time-dependent 
confounders between Y and M1 while L2 the time-dependent confounder between Y and 
M2. Both mediator-outcome confounders (L1 and L2) can be affected by previous 
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covariates including exposure A. The causal relationship among these variables is 
demonstrated in Figure 3.1. Let Y(a, m1, m2) be the counterfactual value of Y given the 
exposure A is set to a and the two mediators M1 and M2 are set to m1 and m2, respectively. 
Let M2(a,m1) be the counterfactual value of M2 given A is set to a and the first mediator 
M1 is set to m1. Let M1(a), M2(a), and Y(a) be the counterfactual values of M1, M2, and Y, 
respectively, given A is set to a. Let G1 and G2 denote random draws from the 
distribution of the mediator M1 and M2, respectively. We use similar definition for G for 
counterfactual models of M. For example, G1(a) is a random draw of M1(a); G2(a,G1(a’)) 
is a random draw of M2(a,G1(a’)), i.e. from the counterfactual value of M2 given A is set 
to a and M1 is set to G1(a’). In addition, we define G12(a) as the random draw of (M1(a), 
M2(a)), i.e. counterfactual outcome of (M1, M2) given A is set to a. Moreover, we also 
make the consistency assumption 
3,5,22
. Under this assumption, Y(a,m1,m2) = Y given A = 
a, M1 = m1, and M2 = m2. M2(a,m1) = M2 given A = a and M1 = m1. M1(a), M2(a), and 
Y(a) are equal to M1, M2, and Y, respectively, given A = a.  
 
Definitions of total effect (TE), control direct effect (CDE), natural direct effect (NDE), 
natural indirect effect (NDE), and the randomly interventional analogues of these effects 
 Let A = a1 and A = a0 denote two hypothetical intervention statuses (for example, 
exposure and non-exposure, respectively).We use counterfactual models described above 
to define all effects of the exposure on the outcome by comparing two exposure levels, a1 
and a0. The total effect (TE) is defined as E[Y(a1)] - E[Y(a0)]. For mediation analysis, the 
total effect is decomposed into direct effect and indirect effect mediated by two mediators, 
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M1 and M2. Two strategies are available for different scientific questions of interest. The 
first strategy assesses direct effect and indirect effect by the controlled direct effect (CDE) 
and the difference of TE and CDE, respectively. CDE is defined as E[Y(a1,m1,m2)] - 
E[Y(a0,m1,m2)], which can be interpreted as the effect of the exposure on the outcome 
while two mediators, M1 and M2, are intervened as certain levels, m1 and m2, respectively. 
The difference between the total effect and the CDE can be used to estimate the extent to 
which the total effect blocked by setting the mediators to a certain level and is valuable 
for questions about policy making. For identifying CDE, we can use two assumptions:  
(1) no unmeasured exposure-outcome confounding (mathematically expressed as 
Y(a,m1,m2) ⊥ A|V)  
(Assumption 1) 
and (2) no unmeasured mediator-outcome confounding (mathematically expressed as 
Y(a,m1,m2)⊥M1|V, A, L1 and Y(a,m1,m2)⊥M2| V, A, L1, M1, L2) 
(Assumption 2).  
Under the above assumptions, CDE can be identified as  
 
Q(a1,m1,m2) - Q(a0,m1,m2) 
 
where Q(a,m1,m2) = 
∑ {∑ E[Y|v, a, l1, m1, l2, m2] × Pr(l1|v, a) × Pr(l2|v, a, l1, m1)l1,l2 }𝑣 Pr(v) 
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Q(a,m1,m2) is the g-formula proposed by Robins 
23
 while A, M1, and M2 are 
intervened as a, m1, and m2. For any random variable W, let w denote W = w in all 
probability function. For example, Pr(l2|v, a, l1, m1) denotes 
Pr(L2 = l2|V = v, A = a, L1 = l1, M1 = m1). 
 For questions about investigation of causal mechanism, one often instead divides the 
TE into a natural direct effect (NDE) and a natural indirect effect (NIE), which are 
defined as the following equations 
5,12,13
: 
 
NDE = Φ(a1, a0) - Φ(a0, a0)  
NIE = Φ(a1, a1) - Φ(a1, a0) 
 
where Φ(a, a’), the standard mediation parameter, is defined as E[Y(a,M1(a’),M2(a’))]. 
NDE expresses the change of outcome given the exposure is changed from a0 to a1, but 
the mediators are kept at the level they would be if the exposure is set to a0. In contrast, 
NIE expresses the change of outcome given the exposure is set to a1 but the mediator is 
changed from the level it will be if exposure is set to a0 to the level it will be if exposure 
is set to a1. To identify the standard mediation parameter (as well as NDE and NIE) 
non-parametrically by empirical data, we have to make four assumptions 
12
:  
(1) Assumption 1,  
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(2) no unmeasured mediator-outcome confounding (mathematically expressed as 
Y(a,m1,m2)⊥(M1, M2)|V, A, L1) 
(Assumption 2-1), 
(3) no unmeasured exposure-mediator confounding (mathematically expressed as A⊥
(M1(a), M2(a))|V) 
(Assumption 3),  
and  
(4) no mediator-outcome confounders are affected by exposure (mathematically 
expressed by Y(a,m1,m2)⊥(M1(a), M2(a))| V) 
(Assumption 4).  
Although Assumption 2 and Assumption 2-1 are both interpreted as “no unmeasured 
mediator-outcome confounding”, the former is weaker than the latter. For example, 
Assumption 2-1 is violated under the presence of a M2-Y confounder affected by M1. 
However, Assumption 2 still holds if this confounder can be measured accurately. 
Under four assumptions, Φ(a, a’), NDE, and NIE can be non-parametrically 
identified as Q(a, a’), Q(a1, a0) - Q(a0, a0), and Q(a1, a1) - Q(a1, a0), respectively, where 
Q(a,a’) = ∑ ∑ E[Y|v, a, m1, m2] Pr(m1, m2|v, a
′)m1,m2𝑣 Pr(v). 
To ensure Assumption 4 held, L1 and L2 should not exist, i.e. there should be no 
mediator-outcome confounders affected by the exposure 
13,24
. This strong assumption can 
be violated even if the two mediators occurred soon after the exposure. Therefore, 
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alternative definitions for NDE and NIE, i.e. randomly interventional analogues of 
natural direct effect (rNDE) and of natural indirect effects (rNIE), have been proposed 
9,17
 
for settings with time-varying confounders 
18-21,25
. rNDE and rNIE are defined as follows:  
 
rNDE = rΦ(a1, a0) - rΦ(a0, a0)  
rNIE = rΦ(a1, a1) - rΦ(a1, a0) 
 
where the rΦ(a, a’), the randomly interventional analogue of Φ(a, a’), is defined as 
E[Y(a,G12(a’))], which replaces (M1(a’), M2(a’)) in Φ(a, a’) by G12(a’). The rNDE 
expresses the change of outcome given the exposure changes from a0 to a1 but mediators 
are set to the value randomly drawn from a distribution of population with exposure is set 
to a0. The rNIE expresses the change of outcome given the exposure is set to a1, but the 
mediator changes from the value randomly drawn from the distribution in the population 
if the exposure were set to a0 to the value randomly drawn from the distribution in the 
population if exposure were set to a1. The sum of rNDE and rNIE are called randomly 
interventional analogue of total effect (rTE).  
In order to identify rΦ (as well as rNDE and rNIE), only three no unmeasured 
foundering assumptions (i.e., Assumption 1, Assumption 2-1, and Assumption 3) are 
required while Assumption 4 is not necessary anymore. Since for multiple mediators, we 
cannot ensure all mediators occurring right after the exposure. The mediator-outcome 
confounders are thus likely to be affected by exposure and Assumption 4 is violated. In 
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next section, we will extend the approach of randomly interventional analogue to define 
path-specific effects in setting with multiple mediators. 
 
Definition and identification of randomly interventional analogues of path-specific 
effects  
In this section, we focus on the simplest case, i.e. the setting with two mediators. 
The notation was introduced in previous section and the causal relationship among all 
covariates is shown in Figure 3.1. When there are two mediators, the number of all 
possible mediator combinations is four. Therefore, TE can be divided into four 
path-specific effects (PSEs) : (1) the path not mediated by M1 or M2 (PSEA→Y), (2) the 
path mediated by M1 only (PSEA→M1→Y), (3) the path mediated by M2 only (PSEA→M2→Y), 
and (4) the path mediated by M1 and then by M2 (PSEA→M1→M2→Y). In general, in settings 
with k mediators, the number of PSEs is 2
k
, which increases exponentially. The approach 
is similar but become more complicated when mediator number is greater than three. 
Therefore, we just demonstrate our method in settings with only three mediators in 
Appendix 3.2 as example.  
Four standard PSEs are defined as follows 
13-15,25
:  
 
PSEASE = Φ(a1, a0, a0, a0) - Φ(a0, a0, a0, a0) 
PSEASM1→S = Φ(a1, a1, a0, a0) - Φ(a1, a0, a0, a0) 
PSEASM2→S = Φ(a1, a1, a1, a0) - Φ(a1, a1, a0, a0) 
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PSEASM1→M2→S = Φ(a1, a1, a1, a1) - Φ(a1, a1, a1, a0)  
 
where Φ(a, a’, a’’, a’’’) is defined as E[Y(a,M1(a’),M2(a’’,M1(a’’’)))]. It is worth to note 
that the PSEA→Y is exactly the NDE and the sum of the other three PSEs is NIE. 
However, even under the absence of time-varying confounder, only PSEA→Y , 
PSEA→M1→Y , and the sum of PSEA→M2→Y  and PSEA→M1→M2→Y  can be 
non-parametrically identified [VW 2014, Avin 2005]. For identifying PSEA→M2→Y and 
PSEA→M1→M2→Y, besides no unmeasured confounding assumption, strong assumptions 
(such as linear SEM) are required 
14,15
.  
Using the similar approach of rNDE and rNIE, we define randomly interventional 
analogues of PSEs (rPSEs): (1) rPSEA→Y, (2) rPSEA→M1→Y, (3) rPSEA→M2→Y, and (4) 
rPSEA→M1→M2→Y. Four rPSEs and rTE can be defined in terms of rΦ(a, a’, a’’, a’’’) as 
follows: 
 
rPSEA→Y = rΦ(a1, a0, a0, a0) - rΦ(a0, a0, a0, a0) 
rPSEA→M1→Y = rΦ(a1, a1, a0, a0) - rΦ(a1, a0, a0, a0) 
rPSEA→M2→Y = rΦ(a1, a1, a1, a0) - rΦ(a1, a1, a0, a0) 
rPSEA→M1→M2→Y = rΦ(a1, a1, a1, a1) - rΦ(a1, a1, a1, a0)  
rTE = rΦ(a1, a1, a1, a1) - rΦ(a0, a0, a0, a0) 
 
79 
 
where rΦ(a, a’, a’’, a’’’) is defined as E[Y(a,G1(a’),G2(a’’,G1(a’’’)))] , which is the 
randomly interventional analogue of Φ(a, a’, a’’, a’’’). The rTE can be decomposed to 
four rPSEs, i.e.  
 
rTE = rPSEA→Y + rPSEA→M1→Y + rPSEA→M2→Y + rPSEA→M1→M2→Y.  
 
Before interpreting all rPSEs and rTE, we first define five populations with 
hypothetical intervention on exposure (and the first mediator). Let population 1 and 
population 0 denote the populations with exposure set to a1 and a0, respectively. Let 
population 1-1 and population 1-0 denote the populations with exposure set to a1 and first 
mediator set to the value randomly drawn from the distribution from population 1 and 
population 0, respectively. Similarly, population 0-0 denotes the population with 
exposure set to a0 and first mediator set to the value randomly drawn from the 
distribution of population 0. Then we can interpret rTE and four rPSEs based on the five 
populations. rTE expresses the change of outcome given the exposure changes from level 
a0 to a1, the first mediator M1 changes from the value randomly drawn from the 
distribution of population 0 to the value randomly drawn from the distribution of 
population 1, and M2 changes from the value randomly drawn from the distribution of 
population 0-0 to the value randomly drawn from the distribution of population 1-1.; rTE 
captures all path from A to Y. rPSEA→Y expresses the change of outcome given the 
exposure changes from level a0 to a1 but the two mediators are set to the values randomly 
drawn from the distribution of population 0 and population 0-0, respectively; this PSE 
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captures the path not mediated by M1 or M2. rPSEA→M1→Y expresses the change of 
outcome given the first mediator M1 changes from the value randomly drawn from the 
distribution of population 0 to the value randomly drawn from the distribution of 
population 1, but the exposure is set to a0 and the second mediator M2 is set to the value 
randomly drown from a distribution of population 0-0; this PSE captures the path 
mediated by M1 only without M2. rPSEA→M2→Y expresses the change of outcome given 
the second mediator M2 changes from the value randomly drawn from the distribution of 
population 0-0 to the value randomly drawn from the distribution of population 1-0, but 
the exposure is set to a1 and the first mediator M1 is set to the value randomly drown from 
a distribution of population 1; this PSE captures the path mediated by M2 only without 
M1. Finally, rPSEA→M1→M2→Y  expresses the change of outcome given the second 
mediator M2 changes from the value randomly drawn from the distribution of population 
1-0 to the value randomly drawn from the distribution of population 1-1, but the exposure 
is set to a1 and the first mediator M1 is set to the value randomly drown from the 
distribution of population 1; this PSE captures the path through M1 followed by M2.  
For identifying rΦ (as well as all rPSEs), we need to make following four no 
unmeasured confounding assumptions:  
(1) Assumption 1, 
(2) Assumption 2,  
(3) no unmeasured exposure-mediator confounding (mathematically expressed as A⊥
(M1(a), M2(a,m1)) |V) 
(Assumption 3-1),  
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and (4) no unmeasured mediator-mediator confounding (mathematically expressed as 
M2(a,m1)⊥M1 |V, A, L1 ) 
(Assumption 5).  
Under the four assumptions, rΦ(a, a’, a’’, a’’’) can be non-parametrically identified as the 
following equations: 
 
rΦ(a, a’, a’’, a’’’)  
= ∑ E[Y(a, m1, m2)]Pr (M1(a
′) = m1)m2m1 ∑ Pr[M2(a
′′, m1′) = m2] Pr (M1(a′′′) =m1′
m1′) 
= Q(a, a’, a’’, a’’’)  
 
where Q(a, a’, a’’, a’’’) =  
∑ E[Y|v, a, l1, m1, l2, m2] Pr(l1|v, a) Pr(l2|v, a, l1, m1) Pr(m1|v, a
′)
v,m2,m1,l1,l2
 
× ∑ Pr(m2|v, a′′, l1′, m1′) Pr(l1′|v, a′′)
m1
′ ,l1′
Pr(m1′|a′′′)Pr (v) 
 
The detail proof is provided in Appendix 3.1, proof A and B.  
All types of rPSEs and rTE can be expressed in terms of Q as follows. 
rPSEA→Y = Q(a1, a0, a0, a0) - Q(a0, a0, a0, a0) 
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rPSEA→M1→Y = Q(a1, a1, a0, a0) - Q(a1, a0, a0, a0) 
rPSEA→M2→Y = Q(a1, a1, a1, a0) - Q(a1, a1, a0, a0) 
rPSEA→M1→M2→Y = Q(a1, a1, a1, a1) - Q(a1, a1, a1, a0)  
rTE = Q(a1, a1, a1, a1) - Q(a0, a0, a0, a0) 
 
The definitions and identification of rPSEs in settings with three mediators are 
provided in Appendix 3.2.  
  
Relation to other causal mediation analysis studies 
We then discuss about the relation of our method to causal mediation analysis. For 
simplicity of expression, we assume that the exposure A was randomly assigned. It can 
be generalized to observational studies by adjusting baseline confounders V. First 
consider that the mediator-outcome confounders are not affected by exposure, i.e. L1 and 
L2 are empty, the randomly interventional analogue of mediation parameter rΦ(a, a’, a’’, 
a’’’) reduces to  
 
∑ E[Y|a, m1, m2]Pr(m1|a′)
m2,m1
× ∑ Pr(m2|a′′, m1′)Pr(m1′|a′′′)
m1
′
 
 
Furthermore, when a’ = a’’’,  rΦ(a, a’, a’’, a’)  
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= ∑ E[Y|a, m1, m2]Pr(m1|a′) Pr(m2|a′′, m1)m2,m1  
 
The proof is provided in Appendix 3.1, proof C. 
The path mediated by M1 (the sum of PSEA→M1→Y and PSEA→M1→M2→Y) can be 
captured by rΦ(a1, a1, a1, a1) - rΦ(a1, a0, a1, a0)  
= ∑ ∑ E[Y|a1, m1, m2]m1 × [Pr(m1|a1) − Pr(m1|a0)] × Pr (m2|a1, m1)m2  
 
and PSEA→M2→Y can be captured by rΦ(a1, a0, a1, a0) - rΦ(a1, a0, a0, a0)  
= ∑ ∑ E[Y|a1, m1, m2]m1 ×  r(m1|a0) × [Pr (m2|a1, m1)m2 − Pr (m2|a0, m1)].  
 
Both formulas have the same form of the path-specific effects in previous studies 
13,25
.  
Then consider a setting with only one mediator, i.e. the L2 and M2 are empty, the 
rΦ(a, a’, a’’, a’’’) reduces to  
 
∑ E[Y|a, l1, m1] Pr(l1|a)m1,l1 Pr(m1|a′)  
 
which is the identification of E[Y(a,G(a’))] 25. When time-varying confounder will not be 
affected by exposure, i.e. all L1, L2, and M2 are all empty, rΦ(a, a’, a’’, a’’’) reduces to 
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∑ E[Y|a, m1]m1 Pr(m1|a′), which is the expression of the standard mediation parameter 
E[Y(a,M1(a’))]. 
 
A regression based approach and illustration 
 In this section, we propose a regression based approach. To obtain a relatively 
simple close form, we aim to obtain the conditional rPSEs rather than the marginal rPSEs. 
We also assume no time-varying confounder affected by exposure and no 
mediator-mediator interaction. In order to match the notation in literature of regression 
based causal mediation analysis 
24,26
, we also replace the notation of baseline confounder 
V by C. 
Consider settings with binary exposure (A = a1 or A = a0), continuous mediators and 
outcome, and no time-varying confounder affected by exposure (Figure 3.2). In addition, 
we also assume linear regression model allowing for exposure-mediator interactions for 
all continuous covariates as below:  
 
E[Y|A = a, M1 = m1, M2 = m2, C = c] = θ0 + θ1a + θ2 m1 + θ3 m2+ θ4 a m1 + θ5 a m2 + θc c 
 
E[M2|A = a, M1 = m1, C = c] = β0 + β1 a + β2 m1 + β3 a m1 +βc c 
 
and E[M1|A = a, C = c] = γ0 + γ1 a + γc c.  
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According to the formula, we can derive the following expressions for four rPSEs: 
 
rPSEA→Y = 
{[θ₁+θ₅(β₀+β₂γ₀+β₂γcc+βcc)+θ₄(γ₀+γcc)]+[θ₄γ₁+θ₅(β₁+β₃γ₀+β₃γcc+β₂γ₁)]a₀+θ₅β₃γ₁a₀²}(
a₁-a₀) 
 
rPSEA→M1→Y = {θ₂γ₁+θ₄γ₁a₁}(a₁-a₀) 
 
rPSEA→M2→Y = {θ₃(β₁+β₃γ₀+β₃γcc)+θ₅(β₁+β₃γ₀+β₃γcc)a₁+θ₃β₃γ₁a₀+θ₅β₃γ₁a₁a₀}(a₁-a₀) 
 
rPSEA→M1→M2→Y = {θ₃β₂γ₁+[(θ₅β₂γ₁+θ₃β₃γ₁)]a₁+θ₅β₃γ₁a₁²}(a₁-a₀) 
 
The proofs are given in Appendix 3.3. Several comments merit to attention. First, 
we include only exposure-mediator interaction here. Similar formulas can be derived 
allowing for mediator-mediator interaction and even three-way interaction (interaction 
term among A, M1, and M2). In Appendix 3.3, we also show the formula including 
mediator-mediator interaction. Second, we propose a SAS macro for applying this 
formula to data in Appendix 3.4. The standard error is estimated by delta method. Third, 
when the baseline confounders are more than one, ie when c = (c1, c2, …, cp)
T
, we just 
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need to replace the θc, βc , and γc by θc
T
 = (θc1, θc2, …, θcp), βc
T
 = (βc1, βc2, …, βcp) , and 
γc
T
 = (γc1, γc2, …, γcp), respectively. Finally, under the above setting as well as no 
exposure-mediator interaction, 𝑟PSEA→Y , rPSEA→M1→Y , rPSEA→M2→Y , and 
rPSEA→M1→M2→Y can be assessed by estimating θ1, α1θ2, β1θ3, and α1β2θ3, respectively, 
which have the same form of path analysis (or SEM) 
27
.  
 
Illustration 
We illustrate the regression based method described above by investigating the 
causal mechanisms of smoking behavior on systolic blood pressure (SBP) mediated by 
cholesterol level and body weight. Beginning in 1948 in Framingham, Massachusetts, the 
original Framingham cohort consisted of 5,209 participants aged from 30 to 62 years 
without cardiovascular disease (CVD) history at baseline. All the participants underwent 
examinations at the beginning of the study and routinely every two years after that. 
During each exam, potential CVD risk factors were collected, including 
socio-demographic data, lifestyle characteristics, detailed medical history, physical 
examination data, and blood samples. Further details on the design of FHS are described 
elsewhere [26, 37]. Four exclusion criteria are listed below: (1) death or loss to follow up 
during the period before exam 7 (the end of follow-up); (2) no record at baseline on 
weight, height, smoking status, former smoking history, SBP, or total cholesterol; (3) 
diagnosis of diabetes, cancer, or CVD at baseline; and (4) value for smoking status or 
BMI missing more than once. In addition, we also eliminate those who quit smoke in 
order to focus on the current smoker versus non-smoker comparison. After these 
exclusions, 2,993 participants are eligible for analysis. SBP (mm-Hg) at exam 7 is the 
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outcome Y and smoking amount is exposure of interest (comparing smoking for 30 
cigarettes per day vs. nonsmoking). The cholesterol level (mg/dL) at exam 4 and BMI 
(kg/m
2
) at exam 6 are two mediators M1 and M2. We include gender, age (years), and 
baseline smoking status (smoker vs. non-smoker) as our baseline confounders. A linear 
regression model is fit for SBP on the cholesterol, BMI, smoking, the interaction between 
smoking and cholesterol level, the interaction between smoking and BMI, and the 
baseline covariates (gender and age). A linear regression model for BMI is fit on the 
smoking, cholesterol level, their interaction, and baseline covariates. A linear regression 
model for cholesterol level is fit on the smoking and baseline covariates. Confidence 
intervals are obtained using the delta method. The SAS code in the context of the rPSE 
decomposition is provided in the Appendix 3.4. We use this decomposition and these 
methods so that we can separate the effect of smoking on SBP mediated directly through 
cholesterol to SBP versus that which changes BMI through changing cholesterol. 
Results are summarized in Table 3.1. Of these 4 rPSEs, the direct effect and effect 
mediated by cholesterol level only are dominant highlighting the important role of 
cholesterol in this context. The effect mediated by BMI is non-significant but has 
different direction from total effect, might indicating the possibility that the adverse 
effect of smoking on increasing blood pressure is partially concealed by body weight loss. 
However, this path is balanced by another path via cholesterol level and then BMI. Our 
results provide evidence that the cholesterol level might play an important role in the 
mechanism of smoking on SBP. 
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Discussion 
To understand the mechanisms with multiple mediators, it is necessary to investigate 
all PSEs. When the mediators affect to each other, the analysis will become complicated 
since one path might be shared by several PSEs. In the setting with two mediators, the 
path from A to M1 belongs to both PSEA→M1→Y and PSEA→M1→M2→Y. Therefore, based 
on standard causal mediation analysis, PSEA→M1→Y  and PSEA→M1→M2→Y  cannot be 
identified separately. Traditional methods such as SEM or path analysis 
27
, however, deal 
with the identification problem by making strong assumption such as linear regression 
model for all covariates without interaction, which may not be applicable in more 
complicated settings. In addition, a linear outcome model is not feasible for most 
epidemiologic studies in which outcome scales are usually binary or time-to-event. 
Daniel et al 
15
 has proposed a method to identify and estimate four PSEs. This method 
requires four assumptions: (1) consistency, (2) no unmeasured confounding among 
exposure, mediators, and outcome, (3) no mediator-outcome confounders affected by 
exposure, and (4) normal distribution for the cross-world counterfactual value of the first 
mediator. The first two assumptions are shared by all causal inference methods and the 
third one, shared by almost all causal mediation analyses, is a relatively strong 
assumption which still can be violated even the two mediators occurs after exposure 
immediately. Under the four assumptions, Daniel et al proposed a sensitivity analysis 
technique to estimate the bounds of the four PSEs 
15
. Our approach, based on definition 
of randomly interventional analogue, requires only the first two assumptions described 
above to identify rPSEs non-parametrically. It allows for flexible choices for all types of 
scales and regression models. In addition, it also adjusts for time-varying confounders, 
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which is applicable for broader settings. However, as discussed above, the definition of 
the effects are slightly different. 
 Several limitations concerning our method merit discussion. First, rather than the 
standard definitions based on cross-world counterfactual outcomes, our method used 
definitions of randomly interventional analogue, which is not exactly how the 
mechanisms perform in nature. In addition, the sum of all rPSEs is rTE, rather than total 
effect of exposure on outcome. However, these effects can be examined in principle in 
randomized controlled trial, while PSEs cannot since PSEs are defined using cross-world 
counterfactual outcomes 
24
. Second, assumptions of no unmeasured confounding are 
required for accurate rPSE estimates. To ensure these assumptions held, researchers 
should collect all potential confounders as comprehensively as possible. When collection 
of all covariates is impossible, sensitivity analysis techniques could be developed to 
assess the extent of bias due to assumption violation. Finally, our SAS code only allows 
linear regression model with exposure-mediator interaction. Methods allowing binary or 
time to event outcome could be developed but are not yet available. For applying this 
method more broadly, more methods and corresponding software should be developed in 
the future. 
In conclusion, our study provides a framework to decompose rTE into several rPSEs 
mediated by all possible combinations of mediators, extending the standard analysis 
method to settings with interaction, non-linearity, and time-varying confounders affected 
by exposure. Our method contributes to investigation of complicated causal mechanisms 
in settings with multiple mediators. 
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Figure 3.1. Causal diagrams for a setting with two mediators and time-varying 
mediator-outcome confounders affected by exposure. 
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Figure 3.2. Causal diagrams for a setting with two mediators but no time-varying 
mediator-outcome confounders. 
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Table 3.1. Proportions of the effect of smoking on systolic blood pressure mediated by cholesterol and/or body mass 
index. 
 Effects (95 % CI) p-value Proportion 
Attributable 
(95 % CI) p-value 
rPSEA→Y 1.9560 (-0.6758, 4.5879) 0.1452 0.6464 (0.2704, 1.0223) 0.0008 
rPSEA→M1→Y 1.0348 (0.4009, 1.6687) 0.0014 0.3419 (0.0109, 0.6730) 0.0429 
rPSEA→M2→Y -0.1655 (-0.8291, 0.4980) 0.6248 -0.05470 (-0.2893, 0.1799) 0.6476 
rPSEA→M1→M2→Y 0.2009 (0.0369, 0.3650) 0.0164 0.06640 (-0.0152, 0.1480) 0.1108 
Effect via M1 (with/without M2) 1.2357 (0.5488, 1.9226) 0.0004 0.4083 (0.0173, 0.7994) 0.0407 
Effect via M2 (with/without M1) 0.03541 (-0.6426, 0.7134) 0.9184 0.01170 (-0.2105, 0.2339) 0.9178 
Effect via M1 or M2 1.0702 (0.1195, 2.0209) 0.0274 0.3536 (-0.0223, 0.7296) 0.0652 
rTE 3.0262 (0.2679, 5.7846) 0.0315 1   
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Appendix 1: Description of mgformula SAS macro for parametric mediational g-formula 
The implementation of causal mediation analysis with time-varying exposures, mediators, 
and confounders 
Introduction 
 The mgformula SAS macro is designed to conduct causal mediation analysis with 
time-varying exposures, mediators, and confounders in longitudinal data. The outcome 
can be a continuous, binary, or time-to-event (i.e. survival) variable. The macro provides 
point estimates and confidence intervals for the overall effect, the direct effect and the 
indirect effect. The estimates are unbiased, under the model and identifiability 
assumptions, which are described elsewhere 
1-3
. Because the mgformula macro is 
specifically developed for time-varying mediators, this macro allows for a fixed exposure 
but not for a fixed mediator. For settings with a fixed exposure and mediator, the 
mediation macro is appropriate and can be freely downloaded on the website 
(http://www.hsph.harvard.edu/causal/software/).  
 
Notation and review for mediational g-formula 
 Consider exposures, mediators, and confounders that vary over time in a 
longitudinal data setting with measurements at time 0, 1, 2, ..., T-1. Let (L(0), L(1), ..., 
L(T-1)), (M(0), M(1), ..., M(T-1)), and (A(0), A(1), ..., A(T-1)) denote values of the 
time-varying confounders, mediators, and exposures at periods 0, 1, ..., T-1, with the final 
outcome of interest Y (or S(T-1) for a survival outcome). The causal relationships among 
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these variables are given in Figure S.1. To accommodate compatibility with the regular 
g-formula macro, although the most common causal relationships follow the order of L, 
A, and M, the current mgformula macro assumes the ordering of the variables as L, M, 
and A. Thus, the data should be structured so that the mediator from the current visit is 
entered along with the exposure from the subsequent visit.  
 For any variable W, let W(t)̅̅ ̅̅ ̅̅  = (W(0), W(1), ..., W(t)) and let W̅ = W(T − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅  = 
(W(0), W(1), ..., W(T-1)). Let Yam̅̅̅̅̅ be the counterfactual outcome given A̅ is set to a̅ 
and if M̅ is set to m̅. Let Ma̅(t) be the counterfactual value of M(t) given A̅ is set to a̅. 
Let Ga̅(t) denote a random draw from the distribution of the mediator M(t)?̅?. In this 
setting, the randomly interventional analogues of total effect (rTE), of natural direct 
effect (rNDE), and of natural indirect effect (rNIE) (representing the overall effect, the 
direct effect, and the indirect effect, respectively) are defined as E[Ya̅Ga̅] − E[Ya∗̅̅ ̅Ga∗̅̅ ̅], 
E[Ya̅Ga∗̅̅ ̅] − E[Ya∗̅̅ ̅Ga∗̅̅ ̅], and E[Ya̅Ga̅] − E[Ya̅Ga∗̅̅ ̅], repectively. The rTE can be decomposed 
into the rNDE and rNIE, i.e. E[Ya̅Ga̅] − E[Ya∗̅̅ ̅Ga∗̅̅ ̅]  = (E[Ya̅Ga∗̅̅ ̅] − E[Ya∗̅̅ ̅Ga∗̅̅ ̅])  + 
(E[Ya̅Ga̅] − E[Ya̅Ga∗̅̅ ̅]). To identify rTE, rNDE, and rNIE, we need to make the three 
following assumptions for all t: (1) Yam̅̅̅̅̅ ⊥ A(t) | A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, M(t)̅̅ ̅̅ ̅̅ , L(t)̅̅ ̅̅ ̅  (no 
exposure-outcome confounding conditional on the past variables, while ⊥ denotes 
independent); (2) Yam̅̅̅̅̅ ⊥ M(t) | A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, M(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, L(t)̅̅ ̅̅ ̅  (no mediator-outcome 
confounding conditional on the past variables); and (3) Ma̅(t) ⊥
A(t)|A(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, M(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, L(t)̅̅ ̅̅ ̅ (no exposure-mediator confounding conditional on the past 
variables) 
1
. Under the three assumptions, the rTE, rNDE and rNIE are identified 
non-parametrically by the following equations: 
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rTE = Q(a̅, a̅) − Q(a∗̅, a∗̅) 
rNDE = Q(a̅, a∗̅) − Q(a∗̅, a∗̅) 
rNIE = Q(a̅, a̅) − Q(a̅, a∗̅) 
 
where Q(a̅1, a̅2) 
=∑ ∑ E[Y|a1̅, m̅, l]̅ ∏ P(l(t)|a1(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ )
T−1
t=0l̅m̅ ×
∑ ∏ P(m(t)|a2(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l′(t)̅̅ ̅̅ ̅)P(l
′(𝑡)|a2(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ , m(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅, l(t − 1)̅̅ ̅̅ ̅̅ ̅̅ ̅̅ )
T−1
t=0l′̅  
 
We refer to E[Ya̅Ga∗̅̅ ̅] as the mediation parameter and Q(a̅1, a̅2) as the mediational 
g-formula. Using the mgformula macro, we can derive the Q(a̅1, a̅2) parametrically and 
then calculate the point estimates and confidence intervals for the rTE, rNDE, and rNIE. 
 
Quick start introduction 
You can follow the four steps below to implement the mgformula macro to your data 
within 5 minutes. The details are described in the next section (“Basic SAS Macro and 
corresponding parameters”). 
Step 1. Prepare your dataset: Prepare a dataset in a person-time format to include a 
subject id, time of follow-up (t), the outcome (Y), the exposures (A), the mediators (M), 
and the confounders (L), as the format in Table S.1. For any random variable W (W can 
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be Y, A, M, or L), Wi(t) represents the observation of W for individual i at time t. Make 
sure the data is completed (no censoring or competing risk). 
 
Step 2. Save and call mgformula macro: Save mgformula macroscript 
("mgformula.sas") in a new file ("file_direction"), and at the top of this program use the 
following %include statement : 
%include ' file_direction/mgformula.sas'; 
Step 3. Define a local macro variable (cov): Specify a gformula macro variable, cov. 
An example of the required syntax for the simple case of one time-varying confounder, L, 
and total times of follow up (T) = 5 is provided below. Time-varying covariates must be 
listed in the order of L, M, and A: 
%let cov= 
 ncov=3 ,  
  cov1= L, cov1otype=1 , cov1ptype=conbin, 
  cov2= M, cov2otype=1 ,cov21ptype=conbin, 
  cov3= A, cov3otype=1, cov3ptype=conbin, 
           seed= 9458; 
Step 4. Specify mgformula parameters and run: run mgformula macro by the 
following statement: 
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%mgformula(datain= , id = , time= , timepoints=, yvar= , yreg=  ,avar= , mvar= ,  
a1value= , a0value= , nboot=) ; 
 Input the name of the data set (datain=), the subject id (id=), the time of observation 
(time=), the overall follow-up time (timepoints=), the outcome variable (yvar=) and its 
model (yreg=), the exposure variable (avar=), and the mediator variable (mvar=). Then 
specify the exposure level a (a1value=) and the baseline level of the exposure a
*
 
(a0value=), and the number of bootstrap samples (nboot=). Three choices for the 
outcome variable models are available: continuous variable (yreg=conteofu), binary 
variable (yreg=bineofu), and binary survival variable (yreg=binsurv).  
 
Basic SAS Macro and corresponding parameters 
 In order to activate the mgformula macro, four steps are required.  
1. Prepare your dataset 
 The dataset has to include the following variables: the subject identification (id), 
time of follow up (t), the outcome (Y), the exposures (A), the mediators (M), and the 
confounders (L(s)). For simplicity, we assume no baseline confounder and only one 
time-varying confounder (L) for the following description. If lagged values of the 
variable (var) are to be used as predictors, then var_l1, var_l2 and var_l3 should be 
included in the dataset. Here, var_lt denotes the variable value measured at t earlier time 
point (t = 1, 2, or 3). We will describe the lag model in covXptype parameter section and 
Table S.3. The data must be arranged with one record per subject per time point (Table 
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S.1-1 and Table S.1-2). The outcome in mgformula macro allows a binary, continuous, or 
survival variable. When analyzing binary or continuous outcome (Y), the Y_l1 is 
recommended to be included in the data as another time-varying confounder. Please refer 
to step 3 “define cov parameter” for more details about defining covariates. The 
mgformula macro internally involves several calls to the “gformula macro” 4 for 
parametric estimation of the standard gformula and relies on the same general input data 
structure. Additional details regarding input dataset requirements are mentioned in the 
gformula SAS macro instruction 
4
. At this time, this approach does not handle competing 
risks or censoring, which will be part of our future work. Therefore, the data must be 
restricted to observations with complete follow-up and no competing risk events.   
 
2. Save and call mgformula macro 
 Open a new SAS session, input the data, save mgformula macroscript 
("mgformula.sas") in a new file ("file_direction"), and at the top of this program use the 
following %include statement: 
 
%include ' file_direction/mgformula.sas'; 
 
3. Define cov parameter 
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In order to specify the baseline confounders and the time-varying covariates (including 
exposures, mediators, and confounders), and their models, we define the "cov" 
parameters by the following statement: 
%let cov= 
 fixedcov = ,   
 ncov=3 ,  
  cov1= L, cov1otype=1 , cov1ptype=conbin, 
  cov2= M, cov2otype=1 ,co21ptype=conbin, 
  cov3= A, cov3otype=1, cov3ptype=conbin, 
           seed= 9458; 
 
 The cov parameters consist of several parameters including fixedcov, ncov, covX, 
covXotype, covXptype, etc, where X = 1, 2, and 3. The limit of X is up to 30. The fixedcov 
parameter specifies baseline confounders (and their models) and the other parameters 
specify the time-varying covariates (and their models). All time-varying exposures, 
mediators, and confounders should be included in time-varying covariates in this step, 
and will be further distinguished in the next step. We describe each parameter as follows. 
 
fixedcov (optional) 
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 The fixedcov parameter specifies the baseline confounder(s). This parameter is 
optional, so it is allowed to be empty. All covariates in the fixedcov parameter will be 
included as predictors of all time-varying covariates models and the outcome model. The 
relationship between baseline confounder(s) and time-varying covariates (and the 
outcome) are assumed linear. The macro cannot transform variables automatically so we 
have to do it manually if we want to. For example, if we plan to include variable "age" as 
a baseline confounder and fit a quadratic linear model, we should create an additional 
variable "age2" which is equal to age
2
, and specify this parameter as "fixedcov = age 
age2".  
 
 The time-varying covariates and their models are defined by several parameters 
listed below. 
ncov (required) 
 The ncov parameter indicates the number of time-varying covariates. For example, if 
we specify three time-varying covariates: time-varying confounder (L), mediator (M), 
and exposure (A), then we should specify this parameter as "ncov=3 ". 
 
For all X = 1, …, ncov: 
covX (required for X = 1) 
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 The covX parameter specifies the X
th
 time-varying covariate to be included in the 
model. The users should specify the mediator and the exposure as the last second 
covariate and the last covariate, respectively. In the setting with three time-varying 
covariates, we should specify cov1, cov2, and cov3 as the time-varying confounder (L), 
the mediator (M), and the exposures (A), respectively. For continuous or binary outcome, 
we recommend to include y_l1 as one of the time-varying confounders (we should create 
y_l1 when preparing the dataset).  
covXotype (required when covX not empty) 
covXptype (required when covX not empty) 
 The mgformula macro fits a parametric model for the distributions of outcome and 
all time-varying covariates conditional on previous covariates. Thus, each time-varying 
covariate is necessary to specify both how it is treated as the dependent variable (outcome 
type or "otype") and how it is treated as a predictor for the outcome and all later covariate 
density models (predictor type or "ptype"). For example, given cov1 is time-varying 
confounder, L. L(1) is used to predict the future variables such as M(1), A(1), L(2), ... , 
and Y. On the other hand, the variables previous to L(1), such as L(0), M(0), and A(0) (as 
well as baseline confounders if they exist), is used as predictors for the distribution of 
L(1). For the model with covX as predictor, we specify covXptype parameter to indicate a 
certain "predictor type" for covX. For the model with covX as the dependent variable, we 
specify covXotype parameter to indicate a certain "outcome type" for covX. Note that at 
this time, the macro can allow a covariate with only one otype and one ptype for different 
models. The complete choices for ptype and otype are summarized in Table 2 and Table 
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3 of the gformula SAS macro instruction
4
. Here, we introduce the most common types as 
follows.  
 Three common outcome types (covXotype = 1, 2, and 3) are summarized in Table 
S.2. When covX is a binary variable, specify covXotype=1. When covX is a survival 
variable, specify covXotype=2. When covX is a continuous variable, specify 
covXotype=3.  
 Several common predictor types for time-varying covariates into the models are 
summarized in Table S.3. The most common choice is "covXptype = conbin", where 
"con" indicates concurrent model and "bin" the binary or linear model. The "con" can be 
replaced by lag1, lag2, or lag3 for different lag models. Again, if lagged values of the 
variable (var) are used as predictors, then var_l1, var_l2 and var_l3 should be prepared 
and included in the dataset. In addition, the bin can also be replaced by qdc, cub, or zqdc, 
for the quadratic, cubic, or zero quadratic model, respectively. For example, the cubic 
lag2 model for cov1 (given cov1 = L) can be specified as "cov1ptype=lag2cub" and both 
L_l1 and L_l2 should be created in the dataset. All possible types are precisely described 
in the gformula macro instruction (GFORMULA SAS macro instruction, Table 3 in the 
Models section). 
 The transformations of the covariates required for predictors are generated 
automatically by them GFORMULA macro and do not need to be included in the dataset. 
Also, to model the full joint distribution of the covariates and outcome, the macro 
imposes the order of covariates as listed and uses the concurrent values of earlier 
covariates to predict all subsequent covariates. 
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seed (optional) 
 Finally, the seed parameter specifies the random numbers seed. The default number 
is 7834. 
 
 The cov parameters are the same as the gformula macro from "fixedcov" to "seed". 
Please refer to the gformula instruction for detailed description. 
 
4. Specify mgformula parameter and run 
 Finally, we specify the mgformula parameters (datain, id, time, timepoints, yvar, 
yreg, avar, mvar, a1value, a0value, and nboot) and call the mgformula macro by the 
statement: 
 
%mgformula(datain= , id = , time= , timepoints=, yvar= , yreg=  ,avar= , mvar= ,  
a1value= , a0value= , nboot=) ; 
 
 We first input the name of the dataset (datain=), the identification (id=), the time of 
observation (time=), the overall follow-up time (timepoints=), the outcome variable 
(yvar=) and its model (yreg=), the exposure variable (avar=), and the mediator variable 
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(mvar=). Then we specify the exposure level a (a1value=) and the baseline level of the 
exposure a* (i.e. non-exposure level) (a0value=), and the number of bootstrapping 
samples (nboot=).Three choices for the outcome variable models are available: 
continuous variable (yreg=conteofu), binary variable (yreg=bineofu), and binary survival 
variable (yreg=binsurv). The paramters datain, yvar, and yreg correspond to the 
GFORMULA parameters data, outc, and outctype, respectively. 
 
Output 
 The output file is like Table S.4. The estimation, standard error, and 95% confidence 
interval for the total effect (TE), direct effect (DE), and indirect effect (IE) are generated. 
We use the original output of Table 1.4 in the manuscript. The regression models and the 
corresponding code we used for the analysis are provided as follows.  
 
Regression models: 
Model 1: 
E[Y|x1(4),x2(4),x3(4),x4(4),x5(4),x1(3),x2(3),x3(3),x4(3),x5(3),c]= β(1)0 + β(1)11x1(4) + 
β(1)12(x1(4))
2
 + β(1)11px1(3) + β(1)12p(x1(3))
2
 + β(1)21I(x2(4)=1) + β(1)22I(x2(4)=2) + 
β(1)21pI(x2(3)=1) + β(1)22pI(x2(3)=2) + β(1)31x3(4) + β(1)32(x3(4))
2
  + β(1)31px3(3) + 
β(1)32p(x3(3))
2
 + β(1)41x4(4) + β(1)42(x4(4))
2
 + β(1)41px4(3) + β(1)42p(x4(3))
2
 + β(1)51x5(4) 
+ β(1)52(x5(4))
2
 + β(1)51px5(3) + β(1)52p(x5(3))
2
 + β(1)cc 
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Model 2: 
logit(E[I(X5(t)=0)|x1(t),x2(t),x3(t),x4(t),x1(t-1),x2(t-1),x3(t-1),x4(t-1),x5(t-1),c]) = β(2)0 + 
β(2)11x1(t) + β(2)12(x1(t))
2
 + β(2)11px1(t-1) + β(2)12p(x1(t-1))
2
 + β(2)21I(x2(t)=1) + 
β(2)22I(x2(t)=2) + β(2)21pI(x2(t-1)=1) + β(2)22pI(x2(t-1)=2) + β(2)31x3(t) + β(2)32(x3(t))
2
  + 
β(2)31px3(t-1) + β(2)32p(x3(t-1))
2
 + β(2)41x4(t) + β(2)42(x4(t))
2
 + β(2)41px4(t-1) + 
β(2)42p(x4(t-1))
2
 + β(2)51px5(t-1) + β(2)52p(x5(t-1))
2
 + β(2)cc 
 
Model 3: 
E[log(X5(t))|x1(t),x2(t),x3(t),x4(t), x5(t)>0, x1(t-1), x2(t-1), x3(t-1), x4(t-1), x5(t-1),c]= β(3)0 
+ β(3)11x1(t) + β(3)12(x1(t))
2
 + β(3)11px1(t-1) + β(3)12p(x1(t-1))
2
 + β(3)21I(x2(t)=1) + 
β(3)22I(x2(t)=2) + β(3)21pI(x2(t-1)=1) + β(3)22pI(x2(t-1)=2) + β(3)31x3(t) + β(3)32(x3(t))
2
  + 
β(3)31px3(t-1) + β(3)32p(x3(t-1))
2
 + β(3)41x4(t) + β(3)42(x4(t))
2
 + β(3)41px4(t-1) + 
β(3)42p(x4(t-1))
2
 + β(3)51px5(t-1) + β(3)52p(x5(t-1))
2
 + β(3)cc 
 
Model 4: 
E[X4(t)|x1(t),x2(t),x3(t), x1(t-1), x2(t-1), x3(t-1), x4(t-1), x5(t-1),c]= β(4)0 + β(4)11x1(t) + 
β(4)12(x1(t))
2
 + β(4)11px1(t-1) + β(4)12p(x1(t-1))
2
 + β(4)21I(x2(t)=1) + β(4)22I(x2(t)=2) + 
β(4)21pI(x2(t-1)=1) + β(4)22pI(x2(t-1)=2) + β(4)31x3(t) + β(4)32(x3(t))
2
  + β(4)31px3(t-1) + 
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β(4)32p(x3(t-1))
2
 + β(4)41x4(t) + β(4)42(x4(t))
2
 + β(4)41px4(t-1) + β(4)42p(x4(t-1))
2
 + 
β(4)51px5(t-1) + β(4)52p(x5(t-1))
2
 + β(4)cc 
 
Model 5: 
E[X3(t)|x1(t),x2(t), x1(t-1), x2(t-1), x3(t-1), x4(t-1), x5(t-1),c]= β(5)0 + β(5)11x1(t) + 
β(5)12(x1(t))
2
 + β(5)11px1(t-1) + β(5)12p(x1(t-1))
2
 + β(5)21I(x2(t)=1) + β(5)22I(x2(t)=2) + 
β(5)21pI(x2(t-1)=1) + β(5)22pI(x2(t-1)=2) + β(5)31px3(t-1) + β(5)32p(x3(t-1))
2
 + β(5)41x4(t) + 
β(5)42(x4(t))
2
 + β(5)41px4(t-1) + β(5)42p(x4(t-1))
2
 + β(5)51px5(t-1) + β(5)52p(x5(t-1))
2
 + β(5)cc 
 
Model 6: 
E[X2(t)|x1(t), x1(t-1), x2(t-1), x3(t-1), x4(t-1), x5(t-1),c]= β(6)0 + β(6)11x1(t) + β(6)12(x1(t))
2
 
+ β(6)11px1(t-1) + β(6)12p(x1(t-1))
2
 + β(6)21pI(x2(t-1)=1) + β(6)22pI(x2(t-1)=2) + 
β(6)31px3(t-1) + β(6)32p(x3(t-1))
2
 + β(6)41x4(t) + β(6)42(x4(t))
2
 + β(6)41px4(t-1) + 
β(6)42p(x4(t-1))
2
 + β(6)51px5(t-1) + β(6)52p(x5(t-1))
2
 + β(6)cc 
 
Model 7: 
E[X1(t)| x1(t-1), x2(t-1), x3(t-1), x4(t-1), x5(t-1),c]= β(7)0 + β(7)11px1(t-1) + β(7)12p(x1(t-1))
2
 
+ β(7)21pI(x2(t-1)=1) + β(7)22pI(x2(t-1)=2) + β(7)31px3(t-1) + β(7)32p(x3(t-1))
2
 + β(7)41x4(t) 
+ β(7)42(x4(t))
2
 + β(7)41px4(t-1) + β(7)42p(x4(t-1))
2
 + β(7)51px5(t-1) + β(7)52p(x5(t-1))
2
 + 
β(7)cc 
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Where c denotes the combination of all fixed covariates; Y denotes the outcome variable; 
xi(t) (i = 1, 2, …, 5) denotes the covi measured at time t (t=0,1,…,4);  β(j) denotes the 
coefficients at model j (j = 1, 2, …, 7).  
 
Code: 
%let mycov= 
       fixedcov =  sex age_0 age2_0 height_0 height2_0 edu2 edu3 edu4 edu5 edu6 
edu7 work2 work3 work4 work5 work6 work7 btuser1 btuser2 marital1 marital2, 
  ncov=5, 
   cov1= sysbp_l1,  cov1otype=3,  cov1ptype=qdc, cov1wherem=exam ne 
0, 
   cov2 = antihbp, cov2otype=3, cov2ptype= skpcat, cov2skip=0 2, 
cov2knots= 1 2, cov2wherem= exam ne 0, 
   cov3= chol, cov3otype=3, cov3ptype=skpqdc,  cov3wherem= exam ne 0, 
   cov4= bmi, cov4otype=3, cov4ptype= lag1qdc, cov4wherem=exam ne 0, 
   cov5= cig, cov5otype=4, cov5ptype= skpqdc, cov5skip = 3, cov5wherem= 
exam ne 0, cov5class=cig3, 
  seed= 7834; 
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%mgformula(datain=data_fhs , id =pid , time=exam , timepoints=5,  
yvar=sysbp_ , yreg=conteofu,  avar=cig , mvar=bmi,  a1value=20, a0value=0, nboot  
= 2) ; 
 
Acknowledgement: 
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Table S.1-1. General form of person-time dataset when outcome is continuous or 
binary variable measured at the end of follow up (Yi). 
id t Yi Ai(t) Mi(t) Li(t) 
1 0  A1(0) M1(0) L1(0) 
1 1  A1(1) M1(1) L1(1) 
1 ...  ... ... ... 
1 T-1 Y1 A1(T-1) M1(T-1) L1(T-1) 
2 0  A2(0) M2(0) L2(0) 
2 1  A2(1) M2(1) L2(1) 
2 ...  ... ... ... 
2 T-1 Y2 A2(T-1) M2(T-1) L2(T-1) 
... ... ... ... ... ... 
n 0  An(0) Mn(0) Ln(0) 
n 1  An(1) Mn(1) Ln(1) 
n ...  ... ... ... 
n T-1 Yn An(T-1) Mn(T-1) Ln(T-1) 
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Table S.1-2. General form of person-time dataset when outcome is survival data 
(Si(t)). 
id t Si(t) Ai(t) Mi(t) Li(t) 
1 0 S1(0) A1(0) M1(0) L1(0) 
1 1 S1(1) A1(1) M1(1) L1(1) 
1 ... ... ... ... ... 
1 T-1 S1(T-1) A1(T-1) M1(T-1) L1(T-1) 
2 0 S2(0) A2(0) M2(0) L2(0) 
2 1 S2(1) A2(1) M2(1) L2(1) 
2 ... ... ... ... ... 
2 T-1 S2(T-1) A2(T-1) M2(T-1) L2(T-1) 
... ... ... ... ... ... 
n 0 Sn(0) An(0) Mn(0) Ln(0) 
n 1 Sn(1) An(1) Mn(1) Ln(1) 
n ... ... ... ... ... 
n T-1 Sn(T-1) An(T-1) Mn(T-1) Ln(T-1) 
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Table S.2. Summary of Outcome Types (otype). 
cov1otype Description Modeled with 
0 Linear change (or constant) * Not modeled 
1 Binary Logistic regression model 
2 Survival Logistic regression model until failure 
3 Continuous Linear regression model 
*The change for each time should be specified in cov1inc parameter 
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Table S.3. Summary of Predictor Types (ptype). 
Cov1ptype description 
con- Concurrent 
lag1- 1 lagged period 
lag2- 2 lagged period 
lag3- 3 lagged period 
-bin Binary or linear 
-qdc Quadratic 
-cub Cubic 
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Table S.4. Output of the mgformula macro. 
 Estimate 95% CI 
E[Y0G0] 135.691 134.93, 137.11 
E[Y1G0] 137.211 135.76, 138.80 
E[Y0G1] 135.336 134.57, 136.69 
E[Y1G1] 136.874 135.64, 138.37 
rTE 1.18 -0.68, 2.69 
rNDE 1.52 -0.25, 2.90 
rNIE -0.34 -0.52, -0.13 
 
rTE: randomly interventional analogue of total effect; rDE: randomly interventional 
analogue of natural direct effect; rIE: randomly interventional analogue of natural 
indirect effect. 
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Figure S.1. Time-varying mediation with ordering of variables of L(t), M(t), and A(t) for t = 0 to T. 
 
 
 
 
 
 
Appendix 2.1. Identication of mediation parameter  (a; a) to the survival
mediational g-formula Q(a,a*)
For simplicity of expression, we dene survivor mediators sM(t) and sG(t) sequentially.
First sM(1) is dened as M(1)a(1) and sG(a) as the random draw of sM(1). For time
= t, the sM(t) is dened as M(1)a(1);sG(1:t 1);s(1:t 1)=1 and sG(t) as the random draw of
sM(t). According to consistency assumption, when A(1 : t) = a(1 : t), M(1 : t   1) =
sG(t  1), and S(t  1) = 1, sM(t) =M(t).
Lemma 1 Given A(1 : t) = a(1 : t);M(1 : t) = m(1 : t); S(1 : t) = 1; sG(1 : t) = m(1 : t),
(1) sG(1 : t) = G(1 : t) = m(1 : t) and S(1 : t) = S(1 : t) = 1, and (2) A(t+1), M(t+1),
and L(t+ 1) are all dened.
step 1. m(1) = sG(1) = G(1) (by denition)
step 2. 1 = S(1) = S(1)a(1);G(1) (by denition)
= S(1)a(1);m(1) (by consistency)
= S(1) (by consistency)
step 3. m(2) = sG(2) = G(2) (since S(1) = 1)
step 4. 1 = S(2) = S(2)a(1:2);G(1:2) = S(2)a(1:2);m(1:2) = S(2) (by denition and
consistency)
We can repeat step 3 and 4 iteratively for t = 3, 4, ...., t, and demonstrate sG(1 : t) =
G(1 : t) = m(1 : t) and S(1 : t) = S(1 : t) = 1. Because S(t) = 1, A(t+ 1), M(t+ 1), and
L(t+ 1) are all dened.
Proof for Identication of mediation parameter  (a; a) to the survival medi-
ational g-formula Q(a,a*)
Under the following four sequential no unmeasured confounding assumptions for t=1, 2,
..., T:
1:S(T )a(1:T );m(1:t);s(1:t 1)=1;G(t+1:T );S(t:T 1) ? A(t)jv; A(1 : t   1) = a(1 : t   1);M(1 :
t  1) = m(1 : t  1); L(1 : t  1); S(1 : t  1) = 1; G(1 : t) = m(1 : t)
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2:S(T )a(1:T );m(1:t);s(1:t 1)=1;G(t+1:T );S(t:T 1) ? M(t)jv; A(1 : t) = a(1 : t);M(1 : t   1) =
m(1 : t  1); L(1 : t  1); S(1 : t  1) = 1; G(1 : t) = m(1 : t)
3:M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? S(t 1)jA(1 : t 1);M(1 : t 1); L(1 : t 1); S(1 : t 2) =
1; v
4:M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? A(t)jA(1 : t 1);M(1 : t 1); L(1 : t 1); S(1 : t 1) = 1; v
(In assumptions 1 and 2, the A(t) and M(t) are dened according to Lemma.)
 (a; a) =
X
v
E[S(T )jv] Pr(v)
E[S(T )jv]  E[S(T )a(1:T );G(1:T );S(1:T 1)jv]
=
X
m(1)
E[S(T )a(1:T );m(1);G(2:T );S(1:T 1)jG(1) = m(1); v] Pr(G(1) = m(1)jv) (add
G(1))
=
X
m(1)
E[S(T )a(1:T );m(1);G(2:T );S(1:T 1)ja(1);m(1); G(1) = m(1); v] Pr(G(1) = m(1)jv)
(add a(1) and m(1) since A(1) ? S(T )a(1:T );m(1);G(2:T );S(1:T 1)jG(1); v
and M(1) ? S(T )a(1:T );m(1);G(2:T );S(1:T 1)jG(1); A(1); v (assumptions 1 and 2 when
t=1))
=
X
m(1)l(1)
E[S(T )a(1:T );m(1);G(2:T );S(1:T 1)ja(1);m(1); l(1); G(1) = m(1); v]
Pr(l(1)ja(1);m(1); v)
Pr(sG(1) = m(1)jv)
(add L(1); by G(1) = sG(1) and l(1) ? G(1)jA(1);M(1); v)
=
X
m(1)l(1)
E[S(T )a(1:T );m(1);s(1)=1;G(2:T );S(2:T 1)ja(1);m(1); l(1); S(1) = 1; G(1) = m(1); v]
Pr(S(1) = 1ja(1);m(1); l(1); G(1) = m(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1) = m(1)jv)
(add S(1)*=1; remind S(1)  S(1)a(1);G(1) and S(T )S(1)=0 = 0)
=
X
m(1)l(1)
E[S(T )a(1:T );m(1);s(1)=1;G(2:T );S(2:T 1)ja(1);m(1); l(1); S(1) = 1; sG(1) =
m(1); v]
E[S(1)ja(1);m(1); l(1); v]
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Pr(l(1)ja(1);m(1); v)
Pr(sG(1) = m(1)jv)
(see proof 1-S1)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1);m(1); l(1); S(1) = 1; sG(1) =
m(1); G(2) = m(2); v]
Pr(G(2) = m(2)ja(1);m(1); l(1); G(1) = m(1); S(1) = 1; v)
E[S(1)ja(1);m(1); l(1); v]
Pr(l(1)ja(1);m(1); v)
Pr(sG(1) = m(1)jv) (add G(2)=m(2))
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1);m(1); l(1); S(1) = 1; sG(1 : 2) =
m(1 : 2); v]
Pr(sG(2) = m(2)ja(1);m(1); l(1); sG(1) = m(1); S(1) = 1; v)
E[S(1)ja(1);m(1); l(1); v]
Pr(l(1)ja(1);m(1); v)
Pr(sG(1) = m(1)jv) (by denition of sG(2) since S(1) = 1)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1);m(1); l(1); S(1) = 1; sG(1 : 2) =
m(1 : 2); v]
E[S(1)ja(1);m(1); l(1); v]
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(see proof 1-G2)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; sG(1 :
2) = m(1 : 2); v]
E(S(1)ja(1);m(1); l(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(add A(2) and M(2)
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since S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1) ? A(2)jv; A(1);M(1); L(1); S(1) = 1; sG(1 :
2) = m(1 : 2) by assumption 1
and S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1) ?M(2)jv; A(1 : 2);M(1); L(1); S(1) = 1; sG(1 :
2) = m(1 : 2) by assumption 2)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) =
1; sG(1 : 2) = m(1 : 2); v]
Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; sG(1 : 2) = m(1 : 2); v)
E(S(1)ja(1);m(1); l(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(add L(2))
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) =
1; sG(1 : 2) = m(1 : 2); v]
Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; v)
E(S(1)ja(1);m(1); l(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(See proof 1-L2)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); S(1 : 2) =
1; sG(1 : 2) = m(1 : 2); v]
E[S(2)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) = 1; sG(1 : 2) = m(1 : 2); v]
Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; v)
E(S(1)ja(1);m(1); l(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(add S(2)=1)
=
X
m(1:2)l(1)
E[S(T )a(1:T );m(1:2);s(1)=1;G(3:T );S(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); S(1 : 2) =
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1; sG(1 : 2) = m(1 : 2); v]
E[S(2)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) = 1; v]
Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; v)
E(S(1)ja(1);m(1); l(1); v)
Pr(l(1)ja(1);m(1); v)
Pr(sG(1 : 2) = m(1 : 2)jv)
(see proof 1-S2)
=
X
m(1:T )l(1:T )
E[S(T )a(1:T );m(1:T );s(T 1)=1ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) =
1; sG(1 : T ) = m(1 : T ); v]

YT 1
t=1
E[S(t)ja(1 : t);m(1 : t); l(1 : t); S(t  1) = 1; v]

YT 1
t=1
Pr(l(t)ja(1 : t);m(1 : t); l(1 : t  1); S(1) = 1; v)
Pr(sG(1 : t) = m(1 : t)jv)
(repeat previous steps iteratively)
=
X
m(1:T )l(1:T )
E[S(T )ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; v]

YT 1
t=1
E[S(t)ja(1 : t);m(1 : t); l(1 : t); S(t  1) = 1; v]

YT 1
t=1
Pr(l(t)ja(1 : t);m(1 : t); l(1 : t  1); S(1) = 1; v)
Pr(sG(1 : T ) = m(1 : T )jv)
(see proof 1-ST)
=
X
m(1:T )l(1:T )
E[S(T )ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; v]

YT 1
t=1
E[S(t)ja(1 : t);m(1 : t); l(1 : t); S(t  1) = 1; v]

YT 1
t=1
Pr(l(t)ja(1 : t);m(1 : t); l(1 : t  1); S(1) = 1; v)

X
ly(1:T 1)
YT
t=1
Pr(m(t)ja(1 : t);m(1 : t  1); ly(1 : t  1); S(t  1) = 1; v)
Pr(ly(t  1)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(t  2) = 1; v)
(see proof 1-GT)
 (a; a) =
X
v
E[S(T )jv] Pr(v)
=
X
v;m(1:T );l(1:T )
E[S(T )ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; v]

YT 1
t=1
E[S(t)ja(1 : t);m(1 : t); l(1 : t); S(t  1) = 1; v]
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
YT 1
t=1
Pr(l(t)ja(1 : t);m(1 : t); l(1 : t  1); S(1) = 1; v)

X
ly(1:T 1)
YT
t=1
Pr(m(t)ja(1 : t);m(1 : t  1); ly(1 : t  1); S(t  1) = 1; v)
Pr(ly(t  1)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(t  2) = 1; v)
Pr(v)
which is the survival mediational g-formula, Q(a,a*).
Proof 1-S1:
Pr(S(1) = 1ja(1);m(1); l(1); G(1) = m(1); v)
= E(S(1)a(1);G(1)ja(1);m(1); l(1); G(1) = m(1); v) (by denition)
= E(S(1)a(1);m(1);l(1)ja(1);m(1); l(1); G(1) = m(1); v) (consistency)
= E(S(1)a(1);m(1);l(1)ja(1);m(1); l(1); v) (since S(1)a(1);m(1);l(1) ? G(1)jA(1);M(1); L(1); v
)
= E(S(1)ja(1);m(1); l(1); v) (consistency)
Proof 1-G2:
Pr(sG(2) = m(2)ja(1);m(1); l(1); sG(1) = m(1); S(1) = 1; v) Pr(sG(1) = m(1)jv)
= Pr(sG(2)
=m(2);sG(1)=m(1)ja(1);m(1);l(1);S(1)=1;v)
Pr(sG(1)=m(1)ja(1);m(1);l(1);S(1)=1;v)  Pr(sG(1) = m(1)jv)
= Pr(sG(2)
=m(2);sG(1)=m(1)jv)
Pr(sG(1)=m(1)jv)  Pr(sG(1) = m(1)jv)
(since sG(1) ? A(1);M(1); L(1); S(1)jv and (sG(1); sG(2)) ? A(1);M(1); L(1); S(1)jv)
= Pr(sG(2) = m(2); sG(1) = m(1)jv) = Pr(sG(1 : 2) = m(1 : 2)jv) (by denition)
Proof 1-L2
Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; sG(1 : 2) = m(1 : 2); v)
= Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; sG(1 : 2) = m(1 : 2); v) (Lemma)
= Pr(l(2)ja(1 : 2);m(1 : 2); l(1); S(1) = 1; v) (since sG(1 : 2) ? l(2)jA(1 : 2);M(1 :
2); L(1); S(1) = 1; v)
Proof 1-S2
E[S(2)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) = 1; sG(1 : 2) = m(1 : 2); v]
= E[S(2)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) = 1; sG(1 : 2) = m(1 : 2); v] (Lemma)
= E[S(2)ja(1 : 2);m(1 : 2); l(1 : 2); S(1) = 1; v] (since sG(1 : 2) ? S(2)jA(1 : 2);M(1 :
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2); L(1 : 2); S(1) = 1; v)
Proof 1-ST
E[S(T )a(1:T );m(1:T );s(T 1)=1ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; sG(1 : T ) =
m(1 : T ); v]
= E[S(T )a(1:T );m(1:T );s(T 1)=1ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; sG(1 : T ) =
m(1 : T ); v] (Lemma)
= E[S(T )ja(1 : T );m(1 : T ); l(1 : T ); S(1 : T   1) = 1; v] (since sG(1 : T ) ?
S(T )jA(1 : T );M(1 : T ); L(1 : T ); S(1 : T   1) = 1; v)
Proof 1-GT
Pr(sG(1 : T ) = m(1 : T )jv)
=
YT
t=1
Pr(sG(1 : t) = m(t)jv)=Pr(sG(1 : t  1) = m(1 : t  1); v)
=
YT
t=1
Pr(sG(1 : t) = m(t)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); S(1 : t   2) =
1; v)=Pr(sG(1 : t   1) = m(1 : t   1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); S(1 : t   2) =
1; v)(since sG(1 : t) ? (A(1 : t  1);M(1 : t  1); L(1 : t  2); S(t  2))jv)
=
YT
t=1
Pr(sG(t) = m(t)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(1 : t  2) = 1; sG(1 :
t  1) = m(1 : t  1); v)
=
YT
t=1
Pr(sM(t) = m(t)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(1 : t  2) = 1; sG(1 :
t  1) = m(1 : t  1); v) (denition of sG(t))
=
YT
t=1
Pr(M(t)a(1:t);m(1:t 1);s(1:t 1)=1 = m(t)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(1 :
t  2) = 1; sG(1 : t  1) = m(1 : t  1); v) (denition of sM(t) and consistency)
=
YT
t=1
X
ly(t)
Pr((M(t)a(1:t);m(1:t 1);s(1:t 1)=1 = m(t)ja(1 : t   1);m(1 : t   1); ly(1 :
t   1); S(1 : t   2) = 1; sG(1 : t   1) = m(1 : t   1); v) Pr(ly(t   1)ja(1 : t   1);m(1 :
t   1); ly(1 : t   2); S(1 : t   2) = 1; v) (add L(t) and sG(1 : t   1) ? L(t   1)jA(1 :
t  1);M(1 : t  1) = sG(1 : t  1) = m(1 : t  1); L(1 : t  2); S(1 : t  2) = 1; v)
=
YT
t=1
X
ly(t)
Pr((M(t)a(1:t);m(1:t 1);s(1:t 1)=1 = m(t)ja(1 : t   1);m(1 : t   1); ly(1 :
t 1); S(1 : t 1) = 1; sG(1 : t 1) = m(1 : t 1); v) Pr(ly(t 1)ja(1 : t 1);m(1 : t 1); ly(1 :
t   2); S(1 : t   2) = 1; v) (add S(t-1) and M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? S(t   1)jA(1 :
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t  1);M(1 : t  1); L(1 : t  1); S(1 : t  2) = 1; v by assumption 3)
=
YT
t=1
X
ly(t)
Pr(M(t)a(1:t);m(1:t 1);s(1:t 1)=1 = m(t)ja(1 : t);m(1 : t   1); ly(1 : t  
1); S(1 : t 1) = 1; sG(1 : t 1) = m(1 : t 1); v) Pr(ly(t 1)ja(1 : t 1);m(1 : t 1); ly(1 :
t  2); S(1 : t  2) = 1; v) (add A(t) by M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? A(t)jA(1 : t  1);M(1 :
t  1) = sG(1 : t  1) = m(1 : t  1); L(1 : t  1); S(1 : t  1) = 1; v by assumption 4)
=
YT
t=1
X
ly(t)
Pr(M(t) = m(t)ja(1 : t);m(1 : t  1); ly(1 : t  1); S(1 : t  1) = 1; sG(1 :
t  1) = m(1 : t  1); v) Pr(ly(t  1)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); S(1 : t  2) = 1; v)
(by consistency)
=
YT
t=1
X
ly(t)
Pr(m(t)ja(1 : t);m(1 : t   1); ly(1 : t   1); S(1 : t   1) = 1; v) Pr(ly(t  
1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); S(1 : t   2) = 1; v) (sG(1 : t   1) ? M(t)jA(1 :
t);M(1 : t  1); L(1 : t  1); S(1 : t  1) = 1)
127
Appendix 2.2. Identication for traditional denition of mediation parameter
(a; a) under the sequential monotonicity assumption
In order to identify the traditional denition of mediation parameter (a; a), we should
make (1) monotonicity assumption, (2) four no unmeasured confounding assumptions, and
(3) crossworld independence assumpion and no Under the monotonicity assumption as below.
(1) monotonicity assumption
S(t)a;m(1:t) > S(t)a;m(1:t) where t  f1; 2; :::; T   1g
(2) the ve sequential no unmeasured confounding assumptions for t=1, 2, ..., T:
1.S(t)a;m(1:t);S(t 1)=1 ? Ajv
2.S(t)a;m(1:t);S(t 1)=1 ?M(k)jv; A;M(1 : k   1); S(k   1) = 1 where k = 1:::t
3.M(t)am(1:t 1)s(t 1)=1 ? S(t  1)jA;M(1 : t  1)
4.M(t)am(1:t 1)s(t 1)=1 ? Ajv
which are similar to the four assumptions in Appendix 1;
(3) a crossworld independence assumption
S(t)a;m(1:t);S(t 1)=1 ? fM(k)am(k 1)s(k 1)=1; k = 1:::tgjv
which holds only under settings without time-varying confounders.
If the monotonicity assumption holds, the (a; a) can be dened. If the above assump-
tions all hold, we can identify the (a; a) as the following expression:X
m(1)
E[S(T )a;m(1:T );S(T 1)=1jv;M(k)am(k 1)s(k 1)=1 = m(k); k = f1; 2; :::; Tg; S(T  
1)a;m(1:T 1) = 1]
TY
t=1
E[S(t)jv; a;m(1 : t); S(t  1) = 1]
TY
t=1
Pr(M(t) = m(t)jA = a;m(1 : t  1); S(t  1) =
1))
(a; a)  E[S(T )aM(1:T )ajv]  E[S(T )aM(1:T )aS(1:T 1)aS(1:T 1)a;M(1:T 1)a jv]
=
X
m(1)
E[S(T )am(1)M(2:T )am(1)S(1:T 1)am(1)S(1:T 1)a;m(1);M(2:T 1)a
jv;M(1)a = m(1)]
Pr(M(1)a = m(1)jv) (add M(1)a*)
=
X
m(1)
E[S(T )am(1)M(2:T )am(1)S(1:T 1)am(1)S(1:T 1)a;m(1);M(2:T 1)a
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jv;M(1)a = m(1)]
Pr(M(1) = m(1)jv; A = a) (M(1)a ? Ajv and consistency)
=
X
m(1)
E[S(T )am(1);S(1)=1;M(2:T )am(1)S(1:T 1)am(1)S(2:T 1)a;m(1);M(2:T 1)a
jv;M(1)a = m(1); S(1)a;m(1) = 1]
E[S(1)a;m(1)jv;M(1)a = m(1)] Pr(M(1) = m(1)jv; A = a) (add S(1))
=
X
m(1)
E[S(T )am(1);S(1)=1;M(2:T )am(1)S(1:T 1)am(1)S(2:T 1)a;m(1);M(2:T 1)a
jv;M(1)a = m(1); S(1)a;m(1) = 1]
E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A = a)
(S(1)a;m(1) ?M(1)a, S(1)a;m(1) ? Ajv,S(1)a;m(1) ?M jv; A,and consistency,)
=
X
m(1)
E[S(T )am(1);S(1)=1;M(2)am(1)S(1)am(1)M(3:T )am(1)S(1:T 1)am(1)S(2:T 1)a;m(1);M(2:T 1)a
jv;M(1)a = m(1); S(1)a;m(1) = 1]
E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A = a) (by denition of M(2:T))
=
X
m(1)
E[S(T )am(1);S(1)=1;M(2)am(1)s(1)=1M(3:T )am(1);s(1)=1;S(2:T 1)am(1)S(2:T 1)a;m(1);M(2:T 1)am(1)s(1)=1
jv;M(1)a = m(1); S(1)a;m(1) = 1]
E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A = a) (by monotonicity assumption S(1)am(1) >
S(1)a;m(1))
=
X
m(1)
E[S(T )a;m(1:2);S(1)=1;M(3:T )am(1:2);s(1)=1;S(2:T 1)am(1:2)S(2:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1)=1
jv;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2)]
Pr(M(2)am(1)s(1)=1 = m(2)jM(1)a = m(1))E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A =
a) (add M(2))
=
X
m(1)
E[S(T )a;m(1:2);S(1)=1;M(3:T )am(1:2);s(1)=1;S(2:T 1)am(1:2)S(2:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1)=1
jv;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2)]
Pr(M(2) = m(2)jA = a;M(1) = m(1); S(1) = 1))E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A =
a)
(M(2)am(1)s(1)=1 ? A, consistency, andM(2)am(1)s(1)=1 ? S(1)jA;M(1), and consistency
again)
=
X
m(1)
E[S(T )a;m(1:2);S(2)=1;M(3:T )am(1:2);s(1)=1;S(2:T 1)am(1:2)S(3:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1)=1 j
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v;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2); S(2)a;m(1:2) = 1]
E[S(2)a;m(1:2)jv;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2)]
Pr(M(2) = m(2)jA = a;M(1) = m(1); S(1) = 1))E[S(1)jv; a;m(1)]
Pr(M(1) = m(1)jv; A = a) (add S(2))
=
X
m(1)
E[S(T )a;m(1:2);S(2)=1;M(3:T )am(1:2);s(1:2)=1;S(3:T 1)am(1:2)S(3:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1:2)=1 j
v;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2); S(2)a;m(1:2) = 1]
E[S(2)a;m(1:2)jv;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2)]
Pr(M(2) = m(2)jA = a;M(1) = m(1); S(1) = 1))
E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A = a)
(by monotonicity assumption S(2)a;m(1:2) > S(2)a;m(1:2))
=
X
m(1)
E[S(T )a;m(1:2);S(2)=1;M(3:T )am(1:2);s(1:2)=1;S(3:T 1)am(1:2)S(3:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1:2)=1 j
v;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2); S(2)a;m(1:2) = 1]
E[S(2)jv; A = a;M(1 : 2) = m(1 : 2); S(1) = 1]
Pr(M(2) = m(2)jA = a;M(1) = m(1); S(1) = 1))
E[S(1)jv; a;m(1)] Pr(M(1) = m(1)jv; A = a)
(S(2)a;m(1:2) ? (A;M(1)a ;M(2)am(1)s(1)=1)jS(1)a;m(1) = 1; v;S(2)a;m(1:2) ?M(1)jA; v;consistency;
S(2)a;m(1:2) ?M(2)jA;M(1); S(1) = 1; v; and consistency)
=
X
m(1)
E[S(T )a;m(1:2);S(2)=1;M(3:T )am(1:2);s(1:2)=1;S(3:T 1)am(1:2)S(3:T 1)a;m(1:2);M(3:T 1)am(1:2)s(1:2)=1 j
v;M(1)a = m(1); S(1)a;m(1) = 1;M(2)am(1)s(1)=1 = m(2); S(2)a;m(1:2) = 1]
2Y
t=1
E[S(t)jv; a;m(1 : t); S(t  1) = 1]
2Y
t=1
Pr(M(t) = m(t)jA = a;m(1 : t  1); S(t  1) = 1)) (change the notation)
...(repeat the above procedure)
=
X
m(1)
E[S(T )a;m(1:T );S(T 1)=1jv;M(k)am(k 1)s(k 1)=1 = m(k); k  f1; 2; :::; Tg; S(T  
1)a;m(1:T 1) = 1]
TY
t=1
E[S(t)jv; a;m(1 : t); S(t  1) = 1]
TY
t=1
Pr(M(t) = m(t)jA = a;m(1 : t  1); S(t  1) =
1))
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=
X
m(1)
E[S(T )jv; a;m(1 : T ); S(T   1) = 1]
TY
t=1
E[S(t)jv; a;m(1 : t); S(t  1) = 1]
TY
t=1
Pr(M(t) = m(t)jA = a;m(1 : t  1); S(t  1) = 1))
(S(T )a;m(1:T );S(T 1)=1 ? Ajv; S(T )a;m(1:T );S(T 1)=1 ?M(t)jv; A;M(1 : t  1); S(t  1) = 1;
and consistency)
=
X
m(1)
E[S(T )a;m(1:T );S(T 1)=1jv;M(k)am(k 1)s(k 1)=1 = m(k); k = f1; 2; :::; Tg; S(T  
1)a;m(1:T 1) = 1]
TY
t=1
E[S(t)jv; a;m(1 : t); S(t  1) = 1]
TY
t=1
Pr(M(t) = m(t)jA = a;m(1 : t  1); S(t  1) = 1))
(S(T )a;m(1:T );S(T 1)=1 ? fM(k)am(k 1)s(k 1)=1; k = 1:::Tgjv)
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Appendix 2.3 Stochastic process version for  (a; a) to the survival mediational
g-formula Q(a,a*)
In this section, the stochastic counting process notation, N(t), is used to replace the
survival variable S(t). We also treat time-varying mediators and confounders as continous
variables. According to the denition of counting process, N(t) = 1   S(t). The identical
denition for S(t)* also applies to the denition of N(t)*.
The mediation parameter,  (a; a), is dened as Pr[N(T ) = 0jv]. Under the following
four sequential no unmeasured confounding assumptions for t=1, 2, ..., T:
1:N(T )a(1:T );m(1:t);N(t 1)=1;G(t+1:T );N(t:T 1) ? A(t)jv; A(1 : t   1) = a(1 : t   1);M(1 :
t  1) = m(1 : t  1); L(1 : t  1); N(1 : t  1) = 0; G(1 : t) = m(1 : t)
2:N(T )a(1:T );m(1:t);N(t 1)=1;G(t+1:T );N(t:T 1) ? M(t)jv; A(1 : t) = a(1 : t);M(1 : t   1) =
m(1 : t  1); L(1 : t  1); N(1 : t  1) = 1; G(1 : t) = m(1 : t)
3:M(t)a(1:t);m(1:t 1);N(t 1)=0 ? N(t 1)jA(1 : t 1);M(1 : t 1); L(1 : t 1); N(t 2) = 0; v
4:M(t)a(1:t);m(1:t 1);N(t 1)=0 ? A(t)jA(1 : t  1);M(1 : t  1); L(1 : t  1); N(t  1) = 0; v
(In assumptions 1 and 2, the A(t) and M(t) are dened according to Lemma.),
 (a; a) can be identied as the survival mediational g-formula, Q(a,a*),
where Q(a,a*)
=
R
m(1:T )l(1:T )
E[1 N(T )ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; v]

YT 1
t=1
E[1 N(t)ja(1 : t);m(1 : t); l(1 : t); N(t  1) = 0; v]

YT 1
t=1
fL(t)(l(t)ja(1 : t);m(1 : t); l(1 : t  1); N(t  1) = 0; v)dl(1 : T )
 R
ly(1:T 1)
YT
t=1
fM(t)(m(t)ja(1 : t);m(1 : t  1); ly(1 : t  1); N(t  1) = 0; v)
fLy(t 1)(ly(t   1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(t   2) = 0; v)dm(1 : T )d
ly(1 : T   1)
The proof is as follows.
Lemma 2 Given A(1 : t) = a(1 : t);M(1 : t) = m(1 : t); N(1 : t) = 0; sG(1 : t) = m(1 : t),
(1) sG(1 : t) = G(1 : t) = m(1 : t) and N(1 : t) = N(1 : t) = 0, and (2) A(t+1), M(t+1),
and L(t+ 1) are all dened.
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step 1. m(1) = sG(1) = G(1) (by denition)
step 2. 0 = N(1) = N(1)a(1);G(1) (by denition)
= N(1)a(1);m(1) (by consistency)
= N(1) (by consistency)
step 3. m(2) = sG(2) = G(2) (since N(1) = 0)
step 4. 0 = N(2) = N(2)a(1:2);G(1:2) = N(2)a(1:2);m(1:2) = N(2) (by denition and
consistency)
We can repeat step 3 and 4 iteratively for t = 3, 4, ...., t, and demonstrate sG(1 : t) =
G(1 : t) = m(1 : t) and N(1 : t) = N(1 : t) = 0. Because N(t) = 0, A(t + 1), M(t + 1),
and L(t+ 1) are all dened.
Proof for Identication of mediation parameter  (a; a) to the survival medi-
ational g-formula Q(a,a*)
Under the following four sequential no unmeasured confounding assumptions for t=1, 2,
..., T:
1:N(T )a(1:T );m(1:t);N(t 1)=1;G(t+1:T );N(t:T 1) ? A(t)jv; A(1 : t   1) = a(1 : t   1);M(1 :
t  1) = m(1 : t  1); L(1 : t  1); N(1 : t  1) = 0; G(1 : t) = m(1 : t)
2:N(T )a(1:T );m(1:t);N(t 1)=1;G(t+1:T );N(t:T 1) ? M(t)jv; A(1 : t) = a(1 : t);M(1 : t   1) =
m(1 : t  1); L(1 : t  1); N(1 : t  1) = 1; G(1 : t) = m(1 : t)
3:M(t)a(1:t);m(1:t 1);N(t 1)=0 ? N(t 1)jA(1 : t 1);M(1 : t 1); L(1 : t 1); N(t 2) = 0; v
4:M(t)a(1:t);m(1:t 1);N(t 1)=0 ? A(t)jA(1 : t  1);M(1 : t  1); L(1 : t  1); N(t  1) = 0; v
(In assumptions 1 and 2, the A(t) and M(t) are dened according to Lemma.)
 (a; a)  E[S(T )jv]  Pr[N(T ) = 0jv] = E[1 N(T )jv]  E[1 N(T )a(1:T );G(1:T );N(1:T 1)jv]
=
R
m(1)
E[1   N(T )a(1:T );m(1);G(2:T );N(1:T 1)jG(1) = m(1); v]fG(1)(m(1)jv)d m(1) (add
G(1))
=
R
m(1)
E[1   N(T )a(1:T );m(1);G(2:T );N(1:T 1)ja(1);m(1); G(1) = m(1); v]fG(1)(m(1)jv)d
m(1) (add a(1) and m(1) since A(1) ? N(T )a(1:T );m(1);G(2:T );N(1:T 1)jG(1); v and M(1) ?
N(T )a(1:T );m(1);G(2:T );N(1:T 1)jG(1); A(1); v (assumptions 1 and 2 when t=1))
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=
R
m(1)l(1)
E[1 N(T )a(1:T );m(1);G(2:T );N(1:T 1)ja(1);m(1); l(1); G(1) = m(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1)(m(1)jv)d l(1)dm(1)
(add L(1); by G(1) = sG(1) and l(1) ? G(1)jA(1);M(1); v)
=
R
m(1)l(1)
E[1 N(T )a(1:T );m(1);N(1)=0;G(2:T );N(2:T 1)ja(1);m(1); l(1); N(1) = 0; G(1) =
m(1); v]
Pr(N(1) = 0ja(1);m(1); l(1); G(1) = m(1); v)fL(1)(l(1)ja(1);m(1); v)fsG(1)(m(1)jv)d
l(1)dm(1)
(add N(1) = 0; remind N(1)  N(1)a(1);G(1) and N(T )N(1)=1 = 1; E[1 N(T )N(1)=1] =
0)
=
R
m(1)l(1)
E[1 N(T )a(1:T );m(1);N(1)=0;G(2:T );N(2:T 1)ja(1);m(1); l(1); N(1) = 0; sG(1) =
m(1); v]
E[1 N(1)ja(1);m(1); l(1); v]fL(1)(l(1)ja(1);m(1); v)fsG(1)(m(1)jv)d l(1)dm(1)
(see proof 1-N1)
=
R
m(1:2)l(1)
E[1 N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1);m(1); l(1); N(1) = 0; sG(1) =
m(1); G(2) = m(2); v]
fG(2)(m(2)ja(1);m(1); l(1); G(1) = m(1); N(1) = 0; v)
E[1 N(1)ja(1);m(1); l(1); v]fL(1)(l(1)ja(1);m(1); v)fsG(1)(m(1)jv)d l(1)dm(1 : 2) (add
G(2)=m(2))
=
R
m(1:2)l(1)
E[1 N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1);m(1); l(1); N(1) = 0; sG(1 :
2) = m(1 : 2); v]
fsG(2)(m(2)ja(1);m(1); l(1); sG(1) = m(1); N(1) = 0; v)
E[1 N(1)ja(1);m(1); l(1); v]fL(1)(l(1)ja(1);m(1); v)fsG(1)(m(1)jv)d l(1)dm(1 : 2) (by
denition of sG(2) since N(1) = 0)
=
R
m(1:2)l(1)
E[1 N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1);m(1); l(1); N(1) = 0; sG(1 :
2) = m(1 : 2); v]
E[1 N(1)ja(1);m(1); l(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1)dm(1 : 2)
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(see proof 1-G2)
=
R
m(1:2)l(1)
E[1   N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1 : 2);m(1 : 2); l(1); N(1) =
0; sG(1 : 2) = m(1 : 2); v]
E[1 N(1)ja(1);m(1); l(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1)dm(1 : 2)
(add A(2) and M(2)
since N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1) ? A(2)jv; A(1);M(1); L(1); N(1) = 0; sG(1 :
2) = m(1 : 2) by assumption 1
andN(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1) ?M(2)jv; A(1 : 2);M(1); L(1); N(1) = 0; sG(1 :
2) = m(1 : 2) by assumption 2)
=
R
m(1:2)l(1)
E[1 N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) =
0; sG(1 : 2) = m(1 : 2); v]
fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; sG(1 : 2) = m(1 : 2); v)
E[1 N(1)ja(1);m(1); l(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1 : 2)dm(1 : 2)
(add L(2))
=
R
m(1:2)l(1)
E[1 N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) =
0; sG(1 : 2) = m(1 : 2); v]
fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; v)
E[1 N(1)ja(1);m(1); l(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1 : 2)dm(1 : 2)
(See proof 1-L2)
=
R
m(1:2)l(1)
E[1   N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); N(1 :
2) = 0; sG(1 : 2) = m(1 : 2); v]
E[1 N(2)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) = 0; sG(1 : 2) = m(1 : 2); v]
fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; v)
E[1 N(1)ja(1);m(1); l(1); v]
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fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1 : 2)dm(1 : 2)
(add N(2)*=0)
=
R
m(1:2)l(1)
E[1   N(T )a(1:T );m(1:2);N(1)=0;G(3:T );N(2:T 1)ja(1 : 2);m(1 : 2); l(1 : 2); N(1 :
2) = 0; sG(1 : 2) = m(1 : 2); v]
E[1 N(2)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) = 0; sG(1 : 2) = m(1 : 2); v]
fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; v)
E[1 N(1)ja(1);m(1); l(1); v]
fL(1)(l(1)ja(1);m(1); v)fsG(1:2)(m(1 : 2)jv)d l(1 : 2)dm(1 : 2)
(see proof 1-N2)
=
R
m(1:T )l(1:T )
E[1 N(T )a(1:T );m(1:T );N(T 1)=0ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) =
0; sG(1 : T ) = m(1 : T ); v]

YT 1
t=1
E[1 N(t)ja(1 : t);m(1 : t); l(1 : t); N(t  1) = 0; v]

YT 1
t=1
fL(t)(l(t)ja(1 : t);m(1 : t); l(1 : t  1); N(t  1) = 0; v)
fsG(1:t)(m(1 : t)jv)d l(1 : T )dm(1 : T )
(repeat previous steps iteratively)
=
R
m(1:T )l(1:T )
E[1 N(T )ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; v]

YT 1
t=1
E[1 N(t)ja(1 : t);m(1 : t); l(1 : t); N(t  1) = 0; v]

YT 1
t=1
fL(t)(l(t)ja(1 : t);m(1 : t); l(1 : t  1); N(t  1) = 0; v)
fsG(1:t)(m(1 : t)jv)d l(1 : T )dm(1 : T )
(see proof 1-NT)
=
R
m(1:T )l(1:T )
E[1 N(T )ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; v]

YT 1
t=1
E[1 N(t)ja(1 : t);m(1 : t); l(1 : t); N(t  1) = 0; v]

YT 1
t=1
fL(t)(l(t)ja(1 : t);m(1 : t); l(1 : t  1); N(t  1) = 0; v)d l(1 : T )
 R
ly(1:T 1)
YT
t=1
fM(t)(m(t)ja(1 : t);m(1 : t  1); ly(1 : t  1); N(t  1) = 0; v)
fLy(t 1)(ly(t   1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(t   2) = 0; v)dm(1 : T )d
ly(1 : T   1)
(see proof 1-GT)
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which is the survival mediational g-formula, Q(a,a*).
Proof 1-N1:
Pr(N(1) = 0ja(1);m(1); l(1); G(1) = m(1); v)
= E(1 N(1)a(1);G(1)ja(1);m(1); l(1); G(1) = m(1); v) (by denition)
= E(1 N(1)a(1);m(1);l(1)ja(1);m(1); l(1); G(1) = m(1); v) (consistency)
= E(1 N(1)a(1);m(1);l(1)ja(1);m(1); l(1); v) (sinceN(1)a(1);m(1);l(1) ? G(1)jA(1);M(1); L(1); v
)
= E(1 N(1)ja(1);m(1); l(1); v) (consistency)
Proof 1-G2:
fsG(2)(m(2)ja(1);m(1); l(1); sG(1) = m(1); N(1) = 0; v) fsG(1)(m(1)jv)
=
fsG(2) (m(2);sG(1)=m(1)ja(1);m(1);l(1);N(1)=0;v)
fsG(1) (m(1)ja(1);m(1);l(1);N(1)=0;v)  fsG(1)(m(1)jv)
=
fsG(2) (m(2);sG(1)=m(1)jv)
fsG(1) (m(1)jv)  fsG(1)(m(1)jv)
(since sG(1) ? A(1);M(1); L(1); N(1)jv and (sG(1); sG(2)) ? A(1);M(1); L(1); N(1)jv)
= f(sG(2) = m(2); sG(1) = m(1)jv) = fsG(1:2)(m(1 : 2)jv) (by denition)
Proof 1-L2
fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; sG(1 : 2) = m(1 : 2); v)
= fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; sG(1 : 2) = m(1 : 2); v) (Lemma)
= fL(2)(l(2)ja(1 : 2);m(1 : 2); l(1); N(1) = 0; v) (since sG(1 : 2) ? l(2)jA(1 : 2);M(1 :
2); L(1); N(1) = 0; v)
Proof 1-N2
E[N(2)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) = 0; sG(1 : 2) = m(1 : 2); v]
= E[N(2)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) = 0; sG(1 : 2) = m(1 : 2); v] (Lemma)
= E[N(2)ja(1 : 2);m(1 : 2); l(1 : 2); N(1) = 0; v] (since sG(1 : 2) ? N(2)jA(1 : 2);M(1 :
2); L(1 : 2); N(1) = 0; v)
Proof 1-NT
E[N(T )a(1:T );m(1:T );s(T 1)=1ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; sG(1 : T ) =
m(1 : T ); v]
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= E[N(T )a(1:T );m(1:T );s(T 1)=1ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; sG(1 : T ) =
m(1 : T ); v] (Lemma)
= E[N(T )ja(1 : T );m(1 : T ); l(1 : T ); N(1 : T   1) = 0; v] (since sG(1 : T ) ?
N(T )jA(1 : T );M(1 : T ); L(1 : T ); N(1 : T   1) = 0; v)
Proof 1-GT
fsG(1:T )(m(1 : T )jv)
=
YT
t=1
fsG(t)(m(t)jv)=fsG(1:t 1)(m(1 : t  1)jv)
=
YT
t=1
fsG(t)(m(t)ja(1 : t 1);m(1 : t 1); ly(1 : t 2); N(1 : t 2) = 0; v)=fsG(1:t 1)(m(1 :
t   1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(1 : t   2) = 0; v)(since sG(1 : t) ? (A(1 :
t  1);M(1 : t  1); L(1 : t  2); N(t  2))jv)
=
YT
t=1
fsG(t)(m(t)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(1 : t   2) = 0; sG(1 :
t  1) = m(1 : t  1); v)
=
YT
t=1
fsM(t)(m(t)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(1 : t   2) = 0; sG(1 :
t  1) = m(1 : t  1); v) (denition of sG(t))
=
YT
t=1
fM(t)a(1:t);m(1:t 1);s(1:t 1)=1(m(t)ja(1 : t 1);m(1 : t 1); ly(1 : t 2); N(1 : t 2) =
0; sG(1 : t  1) = m(1 : t  1); v) (denition of sM(t) and consistency)
=
YT
t=1
R
ly(t) fM(t)a(1:t);m(1:t 1);s(1:t 1)=1(m(t)ja(1 : t   1);m(1 : t   1); ly(1 : t   1); N(1 :
t   2) = 0; sG(1 : t   1) = m(1 : t   1); v)fL(t 1)(ly(t   1)ja(1 : t   1);m(1 : t   1); ly(1 :
t 2); N(1 : t 2) = 0; v)dly(t 1) (add L(t) and sG(1 : t 1) ? L(t 1)jA(1 : t 1);M(1 :
t  1) = sG(1 : t  1) = m(1 : t  1); L(1 : t  2); N(1 : t  2) = 0; v)
=
YT
t=1
R
ly(t) fM(t)a(1:t);m(1:t 1);s(1:t 1)=1(m(t)ja(1 : t   1);m(1 : t   1); ly(1 : t   1); N(1 :
t   1) = 0; sG(1 : t   1) = m(1 : t   1); v)fL(t 1)(ly(t   1)ja(1 : t   1);m(1 : t   1); ly(1 :
t 2); N(1 : t 2) = 0; v)dly(t 1) (add N(t-1) andM(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? N(t 1)jA(1 :
t  1);M(1 : t  1); L(1 : t  1); N(1 : t  2) = 0; v by assumption 3)
=
YT
t=1
R
ly(t) fM(t)a(1:t);m(1:t 1);s(1:t 1)=1(m(t)ja(1 : t);m(1 : t 1); ly(1 : t 1); N(1 : t 1) =
0; sG(1 : t  1) = m(1 : t  1); v)fL(t 1)(ly(t  1)ja(1 : t  1);m(1 : t  1); ly(1 : t  2); N(1 :
t   2) = 0; v)dly(t   1) (add A(t) by M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? A(t)jA(1 : t   1);M(1 :
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t  1) = sG(1 : t  1) = m(1 : t  1); L(1 : t  1); N(1 : t  1) = 0; v by assumption 4)
=
YT
t=1
R
ly(t) fM(t)(m(t)ja(1 : t);m(1 : t 1); ly(1 : t 1); N(1 : t 1) = 0; sG(1 : t 1) =
m(1 : t 1); v)fL(t 1)(ly(t 1)ja(1 : t 1);m(1 : t 1); ly(1 : t 2); N(1 : t 2) = 0; v)dly(t 1)
(by consistency)
=
YT
t=1
R
ly(t) fM(t)(m(t)ja(1 : t);m(1 : t 1); ly(1 : t 1); N(1 : t 1) = 0; v)fL(t 1)(ly(t 
1)ja(1 : t   1);m(1 : t   1); ly(1 : t   2); N(1 : t   2) = 0; v)dly(t   1) (sG(1 : t   1) ?
M(t)jA(1 : t);M(1 : t  1); L(1 : t  1); N(1 : t  1) = 0)
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Appendix 2.4. Assumption 3 with unmeasured survival confounders
In section 3, we mentioned that the four assumptions required for e¤ect identication
allow the unmeasured confounding between survival statuses at di¤erent time points. To
justify this argument, we adapt the non-parametric structural equation model (NPSEM) to
generate one setting with unmeasured survival confounders in which the assumption 3 is still
held.
We describe the causal mechanisms for all variables in Figure 1 by NPSEM as follows:
V = gV ("V )
A?1) = gA1(V; "A1)
M(1) = gM1(V;A(1); "M1)
L(1) = gL1(V;A(1);M(1); "L1)
S(1) = gS1(V;A(1);M(1); L(1); "S1)
and for t=2, . . . , T
A(t) = gAt(V;A(1 : t   1);M(1 : t   1); L(1 : t   1); "At)when S(t   1) = 1; undened
when when S(t  1) = 1
M(t) = gMt(V;A(1 : t);M(1 : t  1); L(1 : t  1); "Mt) when S(t  1) = 1; undened when
when S(t  1) = 1
L(t) = gLt(V;A(1 : t);M(1 : t); L(1 : t 1); "Lt) when S(t 1) = 1; undened when when
S(t  1) = 1
S(t) = gSt(V;A(1 : t);M(1 : t); L(1 : t); S(t  1); "St)
For convenience, we rewrite the assumption 3 by assigning values for the conditioned
random variables, as follows:
M(t)a(1:t);m(1:t 1);s(1:t 1)=1 ? S(t   1)jV = v; A(1 : t   1) = ac(1 : t   1);M(1 : t   1) =
mc(1 : t  1); L(1 : t  1) = lc(1 : t  1); S(1 : t  2) = 1
Under NPSEM and that condition,
M(t)a(1:t);m(1:t 1);s(1:t 1)=1 = gMt(V; a
(1 : t);m(1 : t  1); lc(1 : t  1); "Mt)
S(t  1) = gSt 1(v; ac(1 : t  1);mc(1 : t  1); lc(1 : t  1); S(t  2) = 1; "St 1)
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It is obvious that "Mt and "St 1 are the only random parts of M(t)a(1:t);m(1:t 1);s(1:t 1)=1
and S(t 1), respectively. Therefore, the independence assumption, "Mt ? "St 1jS(t 2) = 1,
is su¢ cient to ensure that the assumption 3 is not violated. A further assumption of no
unmeasured survival confounders (i.e. ("S1 ; : : : ; "St ; : : : ; "ST ) are mutually independent) is
not required.
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Appendix 3.1. Identication of randomly interventional analogue of media-
tion parameter r(a; a0; a00; a000)
Proof A
r(a; a0; a00; a000)  E[Y (a;G1(a0); G2(a00; G1(a000)))]
=
X
m1
E[Y (a;m1; G2(a
00; G1(a000)))jG1(a0) = m1] Pr(G1(a0) = m1) (add G1(a0))
=
X
m1
E[Y (a;m1; G2(a
00; G1(a000)))] Pr(G1(a0) = m1)
(G1(a0) independs to all variables, including G1(a000))
=
X
m1;m2
E[Y (a;m1;m2)jG2(a00; G1(a000)) = m2] Pr(G2(a00; G1(a000)) = m2) Pr(G1(a0) =
m1)
(add G2(a00; G1(a000)))
=
X
m1;m2
E[Y (a;m1;m2)] Pr(G2(a
00; G1(a000)) = m2) Pr(G1(a0) = m1)
(G2(a00; G1(a000)) independs to all variables)
=
X
m1;m2
E[Y (a;m1;m2)] Pr(M2(a
00; G1(a000)) = m2) Pr(M1(a0) = m1)
(G and M have the same distribution)
=
X
m1;m2;m
0
1
E[Y (a;m1;m2)] Pr(M2(a
00;m
0
1) = m2jG1(a000) = m01)
Pr(G1(a
000) = m
0
1) Pr(M1(a
0) = m1)
(add G1(a000))
=
X
m1;m2;m
0
1
E[Y (a;m1;m2)] Pr(M2(a
00;m
0
1) = m2) Pr(G1(a
000) = m
0
1) Pr(M1(a
0) = m1)
(G1(a0) independs to all variables)
=
X
m1;m2;m
0
1
E[Y (a;m1;m2)] Pr(M2(a
00;m
0
1) = m2) Pr(M1(a
000) = m
0
1) Pr(M1(a
0) = m1)
(G and M have the same distribution)
Proof B
All components in the last equation of proof a can be identied as the expression of
g-formula. In order to do that, we need to make four no unmeasured confounding assump-
tions: (1) no unmeasured exposure-outcome confounding (Y (a;m1;m2) ? AjV ), (2) no un-
measured mediator-outcome confounding (Y (a;m1;m2) ? M1jV;A; L1 and Y (a;m1;m2) ?
M2jV;A; L1;M1; L2), (3) no unmeasured exposure-mediator confounding ((M1(a);M2(a;m1) ?
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AjV ), and (4) no unmeasured mediator-mediator confounding (M2(a;m1) ? M1jV;A; L1).
Under the four assumptions, all components can be identied in forms of g-formula as follows.
E[Y (a;m1;m2)jv] =
X
l1;l2
E[Y jv; a; l1;m1; l2;m2] Pr(l1jv; a) Pr(l2jv; a; l1;m1)
Pr(M2(a;m1) = m2jv) =
X
l1
Pr(m2jv; a;m1; l1) Pr(l1jv; a)
Pr(M1(a) = m1jv) = Pr(m1jv; a)
Based on the above three expressions,X
m1;m2;m
0
1
E[Y (a;m1;m2)] Pr(M1(a
0) = m1) Pr(M2(a00;m
0
1) = m2) Pr(M1(a
000) = m
0
1)
=
X
v;m1;m2;m
0
1
E[Y (a;m1;m2)jv] Pr(M1(a0) = m1jv) Pr(M2(a00;m01) = m2jv) Pr(M1(a000) =
m
0
1jv) Pr(v)
=
X
v;m1;m2;l1;l2
E[Y jv; a; l1;m1; l2;m2] Pr(l1jv; a) Pr(l2jv; a; l1;m1) Pr(m1jv; a0)X
l
0
1;m
0
1
Pr(m2jv; a00;m01; l01) Pr(l01jv; a00) Pr(m01jv; a000) Pr(v)
Proof C
r(a; a0; a00; a0)  E[Y (a;G1(a0); G2(a00; G1(a0)))]
=
X
m1
E[Y (a;m1; G2(a
00; G1(a0)))jG1(a0) = m1] Pr(G1(a0) = m1) (add G1(a0))
=
X
m1
E[Y (a;m1; G2(a
00;m1))] Pr(G1(a0) = m1)
(G1(a0) independs to all variables)
=
X
m1;m2
E[Y (a;m1;m2)jG2(a00;m1) = m2] Pr(G2(a00;m1) = m2) Pr(G1(a0) = m1)
(add G2(a00;m1))
=
X
m1;m2
E[Y (a;m1;m2)] Pr(G2(a
00;m1) = m2) Pr(G1(a0) = m1)
(G2(a00;m1) independs to all variables)
=
X
m1;m2
E[Y (a;m1;m2)] Pr(M2(a
00;m1) = m2) Pr(M1(a0) = m1)
(G and M have the same distribution)
=
X
v;m1;m2;l1;l2
E[Y jv; a; l1;m1; l2;m2] Pr(l1jv; a) Pr(l2jv; a; l1;m1) Pr(m1jv; a0)X
l
0
1
Pr(m2jv; a00;m1; l01) Pr(l01jv; a00) Pr(v)
(similar to proof B)
When time-varying confounders V , L1and L2are empty, then
=
X
m1;m2
E[Y jv; a;m1;m2] Pr(m1jv; a0) Pr(m2jv; a00;m1)
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Appendix 3.2
Consider settings with one exposure (A), k mediators (M1;M2; : : : ;Mk), and k sets of
mediator-outcome confounder (L1; L2; : : : ; Lk). For simplicity we assume that the exposure
A was randomly assigned and there is no baseline confounder. Since the number of rPSEs
is 2k and there is no close form for all rPSEs, here we use k = 3 as example to illustrate the
methods.
When k = 3, the number of rPSEs is 23 = 8, which are listed as follows:
rPSEA!Y = r(a1; a0; a0; a0; a0; a0; a0; a0)  r(a0; a0; a0; a0; a0; a0; a0; a0)
rPSEA!M1!Y = r(a1; a1; a0; a0; a0; a0; a0; a0)  r(a1; a0; a0; a0; a0; a0; a0; a0)
rPSEA!M2!Y = r(a1; a1; a1; a0; a0; a0; a0; a0)  r(a1; a1; a0; a0; a0; a0; a0; a0)
rPSEA!M1!M2!Y = r(a1; a1; a1; a1; a0; a0; a0; a0)  r(a1; a1; a1; a0; a0; a0; a0; a0)
rPSEA!M3!Y = r(a1; a1; a1; a1; a1; a0; a0; a0)  r(a1; a1; a1; a1; a0; a0; a0; a0)
rPSEA!M1!M3!Y = r(a1; a1; a1; a1; a1; a1; a0; a0)  r(a1; a1; a1; a1; a1; a0; a0; a0)
rPSEA!M2!M3!Y = r(a1; a1; a1; a1; a1; a1; a1; a0)  r(a1; a1; a1; a1; a1; a1; a0; a0)
rPSEA!M1!M2!M3!Y = r(a1; a1; a1; a1; a1; a1; a1; a1)  r(a1; a1; a1; a1; a1; a1; a1; a0)
r(a(1); a(2); a(3); a(4); a(5); a(6); a(7); a(8)) is dened as
E[Y (a(1); G1(a
(2)); G2(a
(3); G1(a
(4)))G3(a
(5); G1(a
(6)); G2(a
(7); G1(a
(8)))))].
Using the similar procedure in Appendix 3.1, r(a(1); a(2); a(3); a(4); a(5); a(6); a(7); a(8)) =
P
m3
266666664
P
m2
P
m1
E

Y (a(1);m1;m2;m3)
 Pr(M1(a(2)) = m1)	

nP
m01
Pr[M2(a
(3);m01) = m2] Pr(M1(a(4)) = m01)
o
P
m
00
1 ;m
000
1 ;m
0
2
Pr[M3(a
(5);m001;m
0
2) = m3] Pr(M1(a(6)) = m001)
Pr[M2(a(7);m0001 ) = m02] Pr(M1(a(8)) = m0001 )
377777775
.
Under no unmeasured confounding assumptions, each component of above expression can
be identied by the g-formul as follows.
E[Y (a;m1;m2;m3)] =
P
l1;l2;l3
E[Y ja; l1;m1; l2;m2; l3;m3]  Pr(l1ja)  Pr(l2ja; l1;m1) 
Pr(l3ja; l1;m1; l2;m2)
Pr(M1(a) = m1) = Pr(m1ja)
144
Pr[M2(a;m1) = m2] =
X
l1
Pr(m2ja; l1;m1) Pr(l1ja)
Pr[M3(a;m1;m2) = m3] =
X
l1;l2
Pr(m3ja; l1;m1; l2;m2) Pr(l1ja) Pr(l2ja; l1;m1)
We can extend the above formula to any k by the similar procedure.
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Appendix 3.3. A regression-based approach
In Appendix 1, we showed that under four no unmeasured confounding assumptions,
r(a; a0; a00; a000) can be identied as Q(a; a0; a00; a000). In this section, we provide a regression-
based approach for all rPSEs. Consider the mediator-outcome confounders are not a¤ected
by exposure, i.e. L1 and L2 are empty, the randomly interventional analogue of mediation
parameter Q(a; a0; a00; a000) reduces toX
m1;m2;m
0
1
E[Y jc; a;m1;m2] Pr(m1jc; a0) Pr(m2jc; a00;m01) Pr(m01jc; a000)
Then consider linear model for Y , M1, and M2 with interaction term as follows (we omit
high-order interaction term 7am1m2 for simplicity).
E[Y jA = a;M1 = m1;M2 = m2; C = c] = 0 + 1a + 2m1 + 3m2 + 4am1 + 5am2 +
6m1m2 + cc
E[M2jA = a;M1 = m1; C = c] = 0 + 1a+ 2m1 + 3am1 + cc
E[M1jA = a; C = c] = 0 + 1a+ cc:
Therefore,
Q(a; a0; a00; a000)
=
X
m1;m2;m
0
1
E[Y ja;m1;m2] Pr(m1ja0) Pr(m2ja00;m01) Pr(m01ja000)
=
X
m1;m2;m
0
1
(0 + 1a+ 2m1 + 3m2 + 4am1 + 5am2 + 6m1m2 + cc) Pr(m1ja0)
Pr(m2ja00;m01) Pr(m01ja000)
= 0 + cc+ 1a+ (2 + 4a)
X
m1
m1 Pr(m1ja0)
+(3 + 5a)
X
m2;m
0
1
m2 Pr(m2ja00;m01) Pr(m01ja000)
+6
X
m1
m1 Pr(m1ja0)
X
m2;m
0
1
m2 Pr(m2ja00;m01) Pr(m01ja000)
= 0 + cc+ cc+ 1a+ (2 + 4a)E[M1jA = a0]
+((3 + 5a)
X
m
0
1
E[M2jA = a00;M1 = m01] Pr(m01ja000)
+6E[M1jA = a0]
X
m2;m
0
1
E[M2jA = a00;M1 = m01] Pr(m01ja000)
= 0 + cc+ 1a+ (2 + 4a)(0 + 1a
0 + cc)
+((3 + 5a)
X
m
0
1
E[M2jA = a00;M1 = m01] Pr(m01ja000)
+6(0 + 1a
0 + cc)
X
m2;m
0
1
E[M2jA = a00;M1 = m01] Pr(m01ja000)
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= 0 + cc+ 1a+ (2 + 4a)(0 + 1a
0 + cc)
+[(3 + 5a+ 6(0 + 1a
0 + cc)]
X
m
0
1
E[M2jA = a00;M1 = m01] Pr(m01ja000)
= 0 + cc+ 1a+ (2 + 4a)(0 + 1a
0 + cc)
+[(3 + 5a+ 6(0 + 1a
0 + cc)]
X
m
0
1
(0 + 1a
00 + 2m
0
1 + 3a
00m
0
1 + cc) Pr(m
0
1ja000)
= 0 + cc+ 1a+ (2 + 4a)(0 + 1a
0 + cc)
+[(3 + 5a+ 6(0 + 1a
0 + cc)][(0 + 1a
00 + cc) + (2 + 3a
00)E[M1jA = a000]]
= 0 + cc+ 1a+ (2 + 4a)(0 + 1a
0 + cc)
+[(3 + 5a+ 6(0 + 1a
0 + cc)][(0 + 1a
00 + cc) + (2 + 3a
00)(0 + 1a
000 + cc)]
= [0 + cc+ 2(0 + cc) + (3 + 60 + 6cc)(0 + 20 + 2cc+ cc)]
+[1 + 5(0 + 20 + 2cc+ cc) + 4(0 + cc)]a
+[21 + 61(0 + 20 + 2cc+ cc) + 61(0 + 20 + 2cc+ cc)]a
0
+(3 + 60 + 6cc)(1 + 30 + 3cc)a
00 + (3 + 60 + 6cc)21a
000
+41aa
0 + 5(1 + 30 + 3cc)aa
00 + 521aa
000
+61(1 + 30 + 3cc)a
0a00 + 62
2
1a
0a000 + (3 + 60 + 6cc)31a
00a000
+531aa
00a000 + 63
2
1a
0a00a000
and
rPSEA!Y = Q(a1; a0; a0; a0) Q(a0; a0; a0; a0)
=
8>>>><>>>>:
[1 + 5(0 + 20 + 2cc+ cc) + 4(0 + cc)]
+[41 + 5(1 + 30 + 3cc+ 21)]a0
+531a
2
0
9>>>>=>>>>; (a1   a0)
rPSEA!M1!Y = Q(a1; a1; a0; a0) Q(a1; a0; a0; a0)
=
8>>>>>>><>>>>>>>:
(21 + 61(0 + 20 + 2cc+ cc)
+(41)a1
+61(1 + 30 + 3cc)a0
+63
2
1a
2
0
9>>>>>>>=>>>>>>>;
(a1   a0)
rPSEA!M2!Y = Q(a1; a1; a1; a0) Q(a1; a1; a0; a0)
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=8>>>>>>><>>>>>>>:
(3 + 60 + 6cc)(1 + 30 + 3cc)
+(5 + 61)(1 + 30 + 3cc)a1
+(3 + 60 + 6cc)31a0
+(531 + 63
2
1)a1a0
9>>>>>>>=>>>>>>>;
(a1   a0)
rPSEA!M1!M2!Y = Q(a1; a1; a1; a1) Q(a1; a1; a1; a0)
=
8>>>><>>>>:
(3 + 60 + 6cc)21
+[(521 + 62
2
1 + (3 + 60 + 6cc)31)]a1
+(531 + 63
2
1)a
2
1
9>>>>=>>>>; (a1   a0)
Without the mediator-mediator interaction, i.e. 6 = 0, all formulae reduced to
Q(a; a0; a00; a000)
= [0 + cc+ 2(0 + cc) + 3(0 + 20 + 2cc+ cc)]
+[1 + 5(0 + 20 + 2cc+ cc) + 4(0 + cc)]a
+21a
0 + 3(1 + 30 + 3cc)a
00 + 321a
000
+41aa
0 + 5(1 + 30 + 3cc)aa
00 + 521aa
000 + 331a
00a000 + 531aa
00a000
rPSEA!Y
=
8><>: [1 + 5(0 + 20 + 2cc+ cc) + 4(0 + cc)]+[41 + 5(1 + 30 + 3cc+ 21)]a0 + 531a20
9>=>; (a1   a0)
rPSEA!M1!Y = f21 + 41a1g (a1   a0)
rPSEA!M2!Y =
8><>: 3(1 + 30 + 3cc) + 5(1 + 30 + 3cc)a1+331a0 + 531a1a0
9>=>; (a1   a0)
rPSEA!M1!M2!Y = f321 + [(521 + 331)]a1 + 531a21g (a1   a0)
In addition, when interaction terms in outcome model are always zero, i.e. 4 = 5 = 0,
then
rPSEA!Y = 1(a1   a0); rPSEA!M1!Y = 21(a1   a0);
rPSEA!M2!Y = f31 + 330 + 33cc+ 331a0g (a1   a0);
and rPSEA!M1!M2!Y = f321 + 331a1g (a1   a0).
Furthermore, when interaction terms in the second mediator model is zero, i.e. 3 = 0,
then
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rPSEA!Y = 1(a1 a0); rPSEA!M1!Y = 21(a1 a0); rPSEA!M2!Y = 31(a1 a0);
and rPSEA!M1!M2!Y = 321(a1   a0), which have the same form of the path analysis.
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Appendix 3.4. SAS code for randomly interventional analogues of path-
specic e¤ects
This SAS code is developed to estimate the randomly interventional analogues of path-
specic e¤ects (PSE) of exposure A on a continuous outcome Y with continuous mediators
M1 and M2 under the regression models in the A regression based approach and illus-
tration section. Suppose we have a dataset named mydata with outcome variable Y,
exposure variables A, two mediators M1 and M2, and three covariates c1, c2,
and c3. If there were more or fewer covariates the user would have to modify the second
to seven, thirteen, and fourteen lines of the code below to include these covariates. In the
fourth line of code, the user has to specify the two levels of A (a1=1 and a0=0) that are
being compared and the value of the covariates C at which the e¤ects are to be calculated
(cc1=1; cc2=50; cc3=0;), according to the values in the application of interest. The output
demonstrates estimates, condence intervals, and p-value for the total e¤ect, four rPSEs,
the e¤ect via the rst mediator (with/without the second one), the e¤ect via the second
mediator (with/without the rst one), the total indirect e¤ect, and the proportion divided
by total e¤ect.
proc nlmixed data=mydata; /* specify dataset named mydata*/
parms t0=0 t1=0 t2=0 t3=0 t4=0 t5=0 tc1=0 tc2=0 tc3=0 b0=0 b1=0 b2=0 b3=0
bc1=0 bc2=0 bc3=0 r0=0 r1=0 rc1=0 rc2=0 rc3=0 ss_m1=1 ss_m2=1 ss_y=1; /* para-
meter to be estimated*/
a1=1; a0=0; cc1=1; cc2=50; cc3=0; /*parameter to be intervened*/
/* regression model for mean of all variables */
mu_y=t0 + t1*A + t2*M1 + t3*M2 + t4*A*M1 + t5*A*M2 + tc1*C1 + tc2*C2 +
tc3*C3;
mu_m2 =b0 + b1*A + b2*M1 + b3*A*M1 + bc1*C1 + bc2*C2 + bc3*C3;
mu_m1 =r0 + r1*A + rc1*C1 + rc2*C2 + rc3*C3;
/* score function for all variables*/
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ll_y= -((y-mu_y)**2)/(2*ss_y)-0.5*log(ss_y);
ll_m2= -((m2-mu_m2)**2)/(2*ss_m2)-0.5*log(ss_m2);
ll_m1= -((m1-mu_m1)**2)/(2*ss_m1)-0.5*log(ss_m1);
ll_o= ll_m1 + ll_m2 + ll_y;
model Y ~general(ll_o); /* estimate parameters */
/* calculate all estimate we want */
bcc = bc1*cc1 + bc2*cc2 + bc3*cc3;
rcc = rc1*cc1 + rc2*cc2 + rc3*cc3;
pse0 = ((t1+t5*(b0+b2*r0+b2*rcc+bcc)+t4*(r0+rcc))
+(t4*r1+t5*(b1+b3*r0+b3*rcc+b2*r1))*a0+t5*b3*r1*a0*a0)*(a1-a0);
pse1 =(t2*r1+t4*r1*a1)*(a1-a0);
pse2 =(t3*(b1+b3*r0+b3*rcc)
+t5*(b1+b3*r0+b3*rcc)*a1+t3*b3*r1*a0+t5*b3*r1*a1*a0)*(a1-a0);
pse12 =(t3*b2*r1+((t5*b2*r1+t3*b3*r1))*a1+t5*b3*r1*a1*a1)*(a1-a0);
ie1=pse1+pse12;
ie2=pse2+pse12;
ie = pse1+pse2+pse12;
te = pse0+ie;
estimate Direct E¤ectpse0;
estimate Path Specic E¤ect via M1 alonepse1;
estimate Path Specic E¤ect via M2 alonepse2;
estimate Path Specic E¤ect via both M1 and M2pse12;
estimate Path Specic E¤ect via M1 (with/out M2)ie1;
estimate Path Specic E¤ect via M2 (with/out M1)ie2;
estimate Total Indirect E¤ectie;
estimate Total E¤ectte;
estimate Proportion Direct E¤ectpse0/te;
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estimate Proportion via M1pse1/te;
estimate Proportion via M2pse2/te;
estimate Proportion via both M1 and M2pse12/te;
estimate Total Proportion via M1ie1/te;
estimate Total Proportion via M2ie2/te;
estimate Proportion via M1 or M2ie/te;
run;
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